# EDGAR Filing Document

**Accession Number:** 0000910406
**File Stem:** 0000910406-23-000014
**Filing Date:** 2023-2
**Character Count:** 237157
**Document Hash:** 3b0dfc969810f3977a7bc952fde22818
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000910406-23-000014.hdr.sgml**: 20230207

**ACCESSION NUMBER**: 0000910406-23-000014

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 97

**CONFORMED PERIOD OF REPORT**: 20221231

**FILED AS OF DATE**: 20230207

**DATE AS OF CHANGE**: 20230207

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** HAIN CELESTIAL GROUP INC
- **CENTRAL INDEX KEY:** 0000910406
- **STANDARD INDUSTRIAL CLASSIFICATION:** FOOD & KINDRED PRODUCTS [2000]
- **IRS NUMBER:** 223240619
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-22818
- **FILM NUMBER:** 23595055

**BUSINESS ADDRESS:**
- **STREET 1:** 1111 MARCUS AVENUE
- **CITY:** LAKE SUCCESS
- **STATE:** NY
- **ZIP:** 11042
- **BUSINESS PHONE:** 5165875000

**MAIL ADDRESS:**
- **STREET 1:** 1111 MARCUS AVENUE
- **CITY:** LAKE SUCCESS
- **STATE:** NY
- **ZIP:** 11042

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** HAIN FOOD GROUP INC
- **DATE OF NAME CHANGE:** 19941219

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** KINERET ACQUISITION CORP
- **DATE OF NAME CHANGE:** 19931021

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** 21ST CENTURY FOOD PRODUCTS CORP
- **DATE OF NAME CHANGE:** 19930830

?xml version="1.0" ? hain-20221231

**<u>[Table of](#i7551ba622ce34f48a2da5a764b6c3dec_7)[Contents](#i7551ba622ce34f48a2da5a764b6c3dec_7)</u>**

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

___________________________________________

**FORM 10-Q** 

___________________________________________

**(Mark One)**

☒ **Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

**For the quarterly period ended December 31, 2022**

**or**

☐ **Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

**for the transition period from &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; to &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**

**Commission File No. 0-22818** 

___________________________________________

![hain-20221231_g1.jpg](hain-20221231_g1.jpg)

**THE HAIN CELESTIAL GROUP, INC.** 

**(Exact name of registrant as specified in its charter)**

___________________________________________

---

| | |
|:---|:---|
| **Delaware** | **22-3240619** |
| (State or other jurisdiction<br>of incorporation) | (I.R.S. Employer Identification No.) |

---

**1111 Marcus Avenue, Lake Success, NY 11042** 

(Address of principal executive offices, including zip code)

**Registrant's telephone number, including area code: (516) 587-5000** 

**Former name, former address and former fiscal year, if changed since last report: N/A**

___________________________________________

------

**<u>[Table of](#i7551ba622ce34f48a2da5a764b6c3dec_7)[Contents](#i7551ba622ce34f48a2da5a764b6c3dec_7)</u>**

**Securities registered pursuant to Section 12(b) of the Act:** 

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Common Stock, par value $.01 per share | HAIN | The Nasdaq Stock Market LLC |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Yes 🗷&nbsp;&nbsp;&nbsp;&nbsp;No ◻

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes 🗷&nbsp;&nbsp;&nbsp;&nbsp;No ◻

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| Large accelerated filer | ☒ | Accelerated filer | ◻ | | |
| Non-accelerated filer | ◻ | Smaller reporting company | ☐ | Emerging growth company | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes ☐&nbsp;&nbsp;&nbsp;&nbsp;No 🗷

As of January 31, 2023, there were 89,417,250 shares outstanding of the registrant's Common Stock, par value $.01 per share.

------

**<u>[Table of](#i7551ba622ce34f48a2da5a764b6c3dec_7)[Contents](#i7551ba622ce34f48a2da5a764b6c3dec_7)</u>**

**THE HAIN CELESTIAL GROUP, INC.**

**Index**

---

| | | |
|:---|:---|:---|
| | **Part I - Financial Information** | <u>Page</u> |
| Item 1. | <u>[Financial Statements](#i7551ba622ce34f48a2da5a764b6c3dec_16)</u> | |
| | <u>[Consolidated Balance Sheets - December 31, 202](#i7551ba622ce34f48a2da5a764b6c3dec_19)[2](#i7551ba622ce34f48a2da5a764b6c3dec_19)[and June 30, 202](#i7551ba622ce34f48a2da5a764b6c3dec_19)[2](#i7551ba622ce34f48a2da5a764b6c3dec_19)</u> | <u>[3](#i7551ba622ce34f48a2da5a764b6c3dec_19)</u> |
| | <u>[Consolidated Statements of Operations - Three and six months ended December 31, 202](#i7551ba622ce34f48a2da5a764b6c3dec_22)[2](#i7551ba622ce34f48a2da5a764b6c3dec_22)[and 202](#i7551ba622ce34f48a2da5a764b6c3dec_22)[1](#i7551ba622ce34f48a2da5a764b6c3dec_22)</u> | <u>[4](#i7551ba622ce34f48a2da5a764b6c3dec_22)</u> |
| | <u>[Consolidated Statements of Comprehensive Income - Three and six months ended December 31, 2022 and 2021](#i7551ba622ce34f48a2da5a764b6c3dec_25)</u> | <u>[5](#i7551ba622ce34f48a2da5a764b6c3dec_25)</u> |
| | <u>[Consolidated Statement of Stockholders' Equity - Three and six months ended December 31, 202](#i7551ba622ce34f48a2da5a764b6c3dec_28)[2](#i7551ba622ce34f48a2da5a764b6c3dec_28)[and 202](#i7551ba622ce34f48a2da5a764b6c3dec_28)[1](#i7551ba622ce34f48a2da5a764b6c3dec_28)</u> | <u>[6](#i7551ba622ce34f48a2da5a764b6c3dec_28)</u> |
| | <u>[Consolidated Statements of Cash Flows - Six months ended December 31, 202](#i7551ba622ce34f48a2da5a764b6c3dec_34)[2](#i7551ba622ce34f48a2da5a764b6c3dec_34)[and 202](#i7551ba622ce34f48a2da5a764b6c3dec_34)[1](#i7551ba622ce34f48a2da5a764b6c3dec_34)</u> | <u>[8](#i7551ba622ce34f48a2da5a764b6c3dec_34)</u> |
| | <u>[Notes to Consolidated Financial Statements](#i7551ba622ce34f48a2da5a764b6c3dec_37)</u> | <u>[9](#i7551ba622ce34f48a2da5a764b6c3dec_37)</u> |
| Item 2. | <u>[Management's Discussion and Analysis of Financial Condition and Results of Operations](#i7551ba622ce34f48a2da5a764b6c3dec_100)</u> | <u>[33](#i7551ba622ce34f48a2da5a764b6c3dec_100)</u> |
| Item 3. | <u>[Quantitative and Qualitative Disclosures About Market Risk](#i7551ba622ce34f48a2da5a764b6c3dec_121)</u> | <u>[49](#i7551ba622ce34f48a2da5a764b6c3dec_121)</u> |
| Item 4. | <u>[Controls and Procedures](#i7551ba622ce34f48a2da5a764b6c3dec_124)</u> | <u>[50](#i7551ba622ce34f48a2da5a764b6c3dec_124)</u> |
| | **Part II - Other Information** | |
| Items 3 and 4 are not applicable | Items 3 and 4 are not applicable | |
| Item 1. | <u>[Legal Proceedings](#i7551ba622ce34f48a2da5a764b6c3dec_130)</u> | <u>[51](#i7551ba622ce34f48a2da5a764b6c3dec_130)</u> |
| Item 1A. | <u>[Risk Factors](#i7551ba622ce34f48a2da5a764b6c3dec_133)</u> | <u>[51](#i7551ba622ce34f48a2da5a764b6c3dec_133)</u> |
| Item 2. | <u>[Unregistered Sales of Equity Securities and Use of Proceeds](#i7551ba622ce34f48a2da5a764b6c3dec_136)</u> | <u>[51](#i7551ba622ce34f48a2da5a764b6c3dec_136)</u> |
| Item 5. | <u>[Other Information](#i7551ba622ce34f48a2da5a764b6c3dec_139)</u> | &nbsp;&nbsp;<u>[51](#i7551ba622ce34f48a2da5a764b6c3dec_139)</u> |
| Item 6. | <u>[Exhibits](#i7551ba622ce34f48a2da5a764b6c3dec_145)</u> | <u>[52](#i7551ba622ce34f48a2da5a764b6c3dec_145)</u> |
| <u>[Signatures](#i7551ba622ce34f48a2da5a764b6c3dec_148)</u> | | &nbsp;&nbsp;<u>[53](#i7551ba622ce34f48a2da5a764b6c3dec_148)</u> |

---

------

**<u>[Table of](#i7551ba622ce34f48a2da5a764b6c3dec_7)[Contents](#i7551ba622ce34f48a2da5a764b6c3dec_7)</u>**

**Forward-Looking Statements**

This Quarterly Report on Form 10-Q for the quarter ended December 31, 2022 (the "Form 10-Q") contains forward-looking statements within the meaning of safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements involve risks, uncertainties, and assumptions. If the risks or uncertainties ever materialize or the assumptions prove incorrect, the results of The Hain Celestial Group, Inc. (collectively with its subsidiaries, the "Company," "Hain Celestial," "we," "us" or "our") may differ materially from those expressed or implied by such forward-looking statements. The words "believe," "expect," "anticipate," "may," "should," "plan," "intend," "potential," "will" and similar expressions are intended to identify such forward-looking statements. Forward-looking statements include, among other things, our beliefs or expectations relating to our future performance, results of operations and financial condition; foreign exchange and inflation rates; our strategic initiatives, our business strategy, our supply chain, including the availability and pricing of raw materials, our brand portfolio, pricing actions and product performance; current or future macroeconomic trends; and future corporate acquisitions or dispositions.

Risks and uncertainties that may cause actual results to differ materially from forward-looking statements include: challenges and uncertainty resulting from the impact of competition; our ability to manage our supply chain effectively; input cost inflation, including with respect to freight and other distribution costs; foreign currency exchange risk; risks arising from the Russia-Ukraine war; disruption of operations at our manufacturing facilities; reliance on independent contract manufacturers; changes to consumer preferences; customer concentration; reliance on independent distributors; the availability of natural and organic ingredients; risks associated with operating internationally; pending and future litigation, including litigation relating to Earth's Best<sup>®</sup> baby food products; risks associated with outsourcing arrangements; our ability to execute our cost reduction initiatives and related strategic initiatives; our ability to identify and complete acquisitions or divestitures and our level of success in integrating acquisitions; our reliance on independent certification for a number of our products; the reputation of our Company and our brands; our ability to use and protect trademarks; general economic conditions; the United Kingdom's exit from the European Union; cybersecurity incidents; disruptions to information technology systems; the impact of climate change; liabilities, claims or regulatory change with respect to environmental matters; potential liability if our products cause illness or physical harm; the highly regulated environment in which we operate; compliance with data privacy laws; compliance with our credit agreement; the discontinuation of LIBOR; challenges and uncertainty resulting from the COVID-19 pandemic; our ability to issue preferred stock; the adequacy of our insurance coverage; impairments in the carrying value of goodwill or other intangible assets; and other risks and matters described in our most recent Annual Report on Form 10-K, this Form 10-Q and other reports that we file in the future.

We undertake no obligation to update forward-looking statements to reflect actual results or changes in assumptions or circumstances, except as required by applicable law.

------

**<u>[Table of](#i7551ba622ce34f48a2da5a764b6c3dec_7)[Contents](#i7551ba622ce34f48a2da5a764b6c3dec_7)</u>**

**PART I - FINANCIAL INFORMATION**

**ITEM 1. FINANCIAL STATEMENTS**

**THE HAIN CELESTIAL GROUP, INC. AND SUBSIDIARIES**

**CONSOLIDATED BALANCE SHEETS (UNAUDITED)**

**DECEMBER 31, 2022 AND JUNE 30, 2022** 

(In thousands, except par values)

---

| | | |
|:---|:---|:---|
| | **December 31,**<br>**2022** | **June 30,**<br>**2022** |
| **ASSETS** |  |  |
| Current assets: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $43437 | $65512 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable, less allowance for doubtful accounts of $2,085 and $1,731, respectively | 177058 | 170661 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | 324525 | 308034 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | 58781 | 54079 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Assets held for sale | 1500 | 1840 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 605301 | 600126 |
| Property, plant and equipment, net | 294635 | 297405 |
| Goodwill | 927078 | 933796 |
| Trademarks and other intangible assets, net | 470956 | 477533 |
| Investments and joint ventures | 13260 | 14456 |
| Operating lease right-of-use assets, net | 101374 | 114691 |
| Other assets | 25554 | 20377 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $2438158 | $2458384 |
| **LIABILITIES AND STOCKHOLDERS' EQUITY** |  |  |
| Current liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | $153677 | $174765 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued expenses and other current liabilities | 85168 | 86833 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Current portion of long-term debt | 7602 | 7705 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 246447 | 269303 |
| Long-term debt, less current portion | 870800 | 880938 |
| Deferred income taxes | 95131 | 95044 |
| Operating lease liabilities, noncurrent portion | 92587 | 107481 |
| Other noncurrent liabilities | 24552 | 22450 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | 1329517 | 1375216 |
| Commitments and contingencies (Note 16) |  |  |
| Stockholders' equity: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Preferred stock - $.01 par value, authorized 5,000 shares; issued and outstanding: none |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Common stock - $.01 par value, authorized 150,000 shares; issued: 111,256 and 111,090 shares, respectively; outstanding: 89,419 and 89,302 shares, respectively | 1113 | 1111 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Additional paid-in capital | 1210555 | 1203126 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Retained earnings | 786987 | 769098 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | (163346) | (164482) |
|  | 1835309 | 1808853 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less: Treasury stock, at cost, 21,837 and 21,788 shares, respectively | (726668) | (725685) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total stockholders' equity | 1108641 | 1083168 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities and stockholders' equity | $2438158 | $2458384 |

---

*See notes to consolidated financial statements.* 

------

**<u>[Table of](#i7551ba622ce34f48a2da5a764b6c3dec_7)[Contents](#i7551ba622ce34f48a2da5a764b6c3dec_7)</u>**

**THE HAIN CELESTIAL GROUP, INC. AND SUBSIDIARIES**

**CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)**

**FOR THE THREE AND SIX MONTHS ENDED DECEMBER 31, 2022 AND 2021** 

(In thousands, except per share amounts)

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended December 31,** | **Three Months Ended December 31,** | **Six Months Ended December 31,** | **Six Months Ended December 31,** |
| | **2022** | **2021** | **2022** | **2021** |
| Net sales | $454208 | $476941 | $893559 | $931844 |
| Cost of sales | 350351 | 359646 | 695367 | 709131 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gross profit | 103857 | 117295 | 198192 | 222713 |
| Selling, general and administrative expenses | 72357 | 80136 | 147308 | 153929 |
| Amortization of acquired intangible assets | 2785 | 2049 | 5573 | 4144 |
| Productivity and transformation costs | 986 | 2786 | 1759 | 6769 |
| Long-lived asset impairment | 340 | 303 | 340 | 303 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating income | 27389 | 32021 | 43212 | 57568 |
| Interest and other financing expense, net | 10812 | 2592 | 18489 | 4448 |
| Other income, net | (1062) | (9070) | (2852) | (9858) |
| &nbsp;&nbsp;&nbsp;Income before income taxes and equity in net loss of equity-method investees | 17639 | 38499 | 27575 | 62978 |
| Provision for income taxes | 6357 | 7145 | 8988 | 11687 |
| Equity in net loss of equity-method investees | 316 | 465 | 698 | 991 |
| Net income | $10966 | $30889 | $17889 | $50300 |
| Net income per common share: |  |  |  |  |
| Basic | $0.12 | $0.33 | $0.20 | $0.53 |
| Diluted | $0.12 | $0.33 | $0.20 | $0.52 |
| Shares used in the calculation of net income per common share: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic | 89380 | 94036 | 89343 | 95579 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted | 89578 | 94808 | 89535 | 96123 |

---

*See notes to consolidated financial statements.*

------

**<u>[Table of](#i7551ba622ce34f48a2da5a764b6c3dec_7)[Contents](#i7551ba622ce34f48a2da5a764b6c3dec_7)</u>**

**THE HAIN CELESTIAL GROUP, INC. AND SUBSIDIARIES**

**CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)**

**FOR THE THREE AND SIX MONTHS ENDED DECEMBER 31, 2022 AND 2021**

(In thousands)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** |
| | **December 31, 2022** | **December 31, 2022** | **December 31, 2022** | **December 31, 2021** | **December 31, 2021** | **December 31, 2021** |
| | **Pre-tax** <br>**amount** | **Tax (expense) benefit** | **After-tax amount** | **Pre-tax** <br>**amount** | **Tax (expense) benefit** | **After-tax amount** |
| Net income |  |  | $10966 |  |  | $30889 |
| Other comprehensive income (loss): |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Foreign currency translation adjustments before reclassifications | 59674 |  | 59674 | (2143) |  | (2143) |
| &nbsp;&nbsp;&nbsp;Change in deferred (losses) gains on cash flow hedging instruments | (2475) | 610 | (1865) | 682 | (144) | 538 |
| &nbsp;&nbsp;&nbsp;Change in deferred gains on fair value hedging instruments | 691 | (170) | 521 |  |  |  |
| &nbsp;&nbsp;&nbsp;Change in deferred (losses) gains on net investment hedging instruments | (6285) | 1553 | (4732) | 1709 | (360) | 1349 |
| Total other comprehensive income (loss) | $51605 | $1993 | $53598 | $248 | $(504) | $(256) |
| Total comprehensive income |  |  | $64564 |  |  | $30633 |
|  | **Six Months Ended** | **Six Months Ended** | **Six Months Ended** | **Six Months Ended** | **Six Months Ended** | **Six Months Ended** |
|  | **December 31, 2022** | **December 31, 2022** | **December 31, 2022** | **December 31, 2021** | **December 31, 2021** | **December 31, 2021** |
|  | **Pre-tax <br>amount** | **Tax (expense) benefit** | **After-tax amount** | **Pre-tax <br>amount** | **Tax (expense) benefit** | **After-tax amount** |
| Net income |  |  | $17889 |  |  | $50300 |
| Other comprehensive income (loss): |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Foreign currency translation adjustments before reclassifications | (7476) |  | (7476) | (24948) |  | (24948) |
| &nbsp;&nbsp;&nbsp;Change in deferred gains on cash flow hedging instruments | 11755 | (3028) | 8727 | 726 | (153) | 573 |
| &nbsp;&nbsp;&nbsp;Change in deferred gains on fair value hedging instruments | 418 | (100) | 318 |  |  |  |
| &nbsp;&nbsp;&nbsp;Change in deferred (losses) gains on net investment hedging instruments | (511) | 78 | (433) | 3997 | (841) | 3156 |
| Total other comprehensive income (loss) | $4186 | $(3050) | $1136 | $(20225) | $(994) | $(21219) |
| Total comprehensive income |  |  | $19025 |  |  | $29081 |

---

*See notes to consolidated financial statements.*

------

**<u>[Table of](#i7551ba622ce34f48a2da5a764b6c3dec_7)[Contents](#i7551ba622ce34f48a2da5a764b6c3dec_7)</u>**

**THE HAIN CELESTIAL GROUP, INC. AND SUBSIDIARIES** 

**CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (UNAUDITED)**

**FOR THE THREE AND SIX MONTHS ENDED DECEMBER 31, 2022**

(In thousands, except par values)

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | Common Stock | Common Stock | | | | | | |
| | | | | | Treasury Stock | Treasury Stock | | |
| |<br>Shares | Amount<br>at $.01 | Additional<br>Paid-in<br>Capital |<br>Retained<br>Earnings | Shares | Amount | Accumulated<br>Other<br>Comprehensive<br>Loss |<br>Total |
| Balance at June 30, 2022 | 111090 | $1111 | $1203126 | $769098 | 21788 | $(725685) | $(164482) | $1083168 |
| Net income |  |  |  | 6923 |  |  |  | 6923 |
| Other comprehensive loss |  |  |  |  |  |  | (52462) | (52462) |
| Issuance of common stock pursuant to stock-based compensation plans | 24 | 1 |  |  |  |  |  | 1 |
| Employee shares withheld for taxes |  |  |  |  | 10 | (229) |  | (229) |
| Stock-based compensation expense |  |  | 3994 |  |  |  |  | 3994 |
| Balance at September 30, 2022 | **111114** | **1112** | **1207120** | **776021** | **21798** | **(725914)** | **(216944)** | **1041395** |
| Net income |  |  |  | 10966 |  |  |  | 10966 |
| Other comprehensive income |  |  |  |  |  |  | 53598 | 53598 |
| Issuance of common stock pursuant to stock-based compensation plans | 142 | 1 |  |  |  |  |  | 1 |
| Employee shares withheld for taxes |  |  |  |  | 39 | (754) |  | (754) |
| Stock-based compensation expense |  |  | 3435 |  |  |  |  | 3435 |
| Balance at December 31, 2022 | **111256** | $**1113** | $**1210555** | $**786987** | **21837** | $**(726668)** | $**(163346)** | $**1108641** |

---

*See notes to consolidated financial statements.*

------

**<u>[Table of](#i7551ba622ce34f48a2da5a764b6c3dec_7)[Contents](#i7551ba622ce34f48a2da5a764b6c3dec_7)</u>**

**THE HAIN CELESTIAL GROUP, INC. AND SUBSIDIARIES** 

**CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (UNAUDITED)**

**FOR THE THREE AND SIX MONTHS ENDED DECEMBER 31, 2021** 

(In thousands, except par values)

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | Common Stock | Common Stock | | | | | | |
| | | | | | Treasury Stock | Treasury Stock | | |
| |<br>Shares | Amount<br>at $.01 | Additional<br>Paid-in<br>Capital |<br>Retained<br>Earnings | Shares | Amount | Accumulated<br>Other<br>Comprehensive<br>Loss |<br>Total |
| Balance at June 30, 2021 | 109507 | $1096 | $1187530 | $691225 | 10438 | $(283957) | $(73011) | $1522883 |
| Net income |  |  |  | 19411 |  |  |  | 19411 |
| Other comprehensive loss |  |  |  |  |  |  | (20963) | (20963) |
| Issuance of common stock pursuant to stock-based compensation plans | 61 |  |  |  |  |  |  |  |
| Employee shares withheld for taxes |  |  |  |  | 29 | (1175) |  | (1175) |
| Repurchase of common stock |  |  |  |  | 4525 | (175687) |  | (175687) |
| Stock-based compensation expense |  |  | 4287 |  |  |  |  | 4287 |
| Balance at September 30, 2021 | **109568** | **1096** | **1191817** | **710636** | **14992** | **(460819)** | **(93974)** | **1348756** |
| Net income |  |  |  | 30889 |  |  |  | 30889 |
| Other comprehensive loss |  |  |  |  |  |  | (256) | (256) |
| Issuance of common stock pursuant to stock-based compensation plans | 1436 | 14 | (14) |  |  |  |  |  |
| Employee shares withheld for taxes |  |  |  |  | 654 | (29858) |  | (29858) |
| Repurchase of common stock |  |  |  |  | 2027 | (89831) |  | (89831) |
| Stock-based compensation expense |  |  | 4156 |  |  |  |  | 4156 |
| Balance at December 31, 2021 | **111004** | $**1110** | $**1195959** | $**741525** | **17673** | $**(580508)** | $**(94230)** | $**1263856** |

---

*See notes to consolidated financial statements.*

------

**<u>[Table of](#i7551ba622ce34f48a2da5a764b6c3dec_7)[Contents](#i7551ba622ce34f48a2da5a764b6c3dec_7)</u>**

**THE HAIN CELESTIAL GROUP, INC. AND SUBSIDIARIES** 

**CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)**

**FOR THE SIX MONTHS ENDED DECEMBER 31, 2022 AND 2021**

(In thousands)

---

| | | |
|:---|:---|:---|
| | **Six Months Ended December 31,** | **Six Months Ended December 31,** |
| | **2022** | **2021** |
| CASH FLOWS FROM OPERATING ACTIVITIES |  |  |
| Net income | $17889 | $50300 |
| Adjustments to reconcile net income to net cash (used in) provided by operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 24125 | 21758 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred income taxes | (1983) | (3271) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Equity in net loss of equity-method investees | 698 | 991 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation, net | 7429 | 8443 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Long-lived asset impairment | 340 | 303 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain on sale of assets | (3395) | (8921) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other non-cash items, net | (2505) | (1486) |
| (Decrease) increase in cash attributable to changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable | (6536) | 12370 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | (18629) | 2473 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other current assets | (331) | (5126) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other assets and liabilities | 4178 | 1776 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and accrued expenses | (23932) | (11579) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash (used in) provided by operating activities | (2652) | 68031 |
| CASH FLOWS FROM INVESTING ACTIVITIES |  |  |
| Purchases of property, plant and equipment | (14055) | (27996) |
| Acquisitions of businesses, net of cash acquired |  | (254569) |
| Investments and joint ventures, net | 433 | (514) |
| Proceeds from sale of assets | 7608 | 10734 |
| &nbsp;&nbsp;&nbsp;Net cash used in investing activities | (6014) | (272345) |
| CASH FLOWS FROM FINANCING ACTIVITIES |  |  |
| Borrowings under bank revolving credit facility | 185000 | 540000 |
| Repayments under bank revolving credit facility | (194750) | (330000) |
| Borrowings under term loan |  | 300000 |
| Payments of other debt, net | (159) | (3185) |
| Share repurchases |  | (266933) |
| Employee shares withheld for taxes | (983) | (31033) |
| &nbsp;&nbsp;&nbsp;Net cash (used in) provided by financing activities | (10892) | 208849 |
| Effect of exchange rate changes on cash | (2517) | (3204) |
| Net (decrease) increase in cash and cash equivalents | (22075) | 1331 |
| Cash and cash equivalents at beginning of period | 65512 | 75871 |
| Cash and cash equivalents at end of period | $43437 | $77202 |

---

*See notes to consolidated financial statements.*

------

**<u>[Table of](#i7551ba622ce34f48a2da5a764b6c3dec_7)[Contents](#i7551ba622ce34f48a2da5a764b6c3dec_7)</u>**

**THE HAIN CELESTIAL GROUP, INC. AND SUBSIDIARIES**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)**

(Amounts in thousands, except par values and per share data)

**1.&nbsp;&nbsp;&nbsp;&nbsp;BUSINESS**

The Hain Celestial Group, Inc., a Delaware corporation (collectively with its subsidiaries, the "Company," "Hain Celestial," "we," "us" or "our"), was founded in 1993 and is headquartered in Lake Success, New York. The Company's mission has continued to evolve since its founding, with health and wellness being the core tenet. The Company continues to be a leading marketer, manufacturer, and seller of organic and natural, "better-for-you" products by anticipating and exceeding consumer expectations in providing quality, innovation, value and convenience. The Company is committed to growing sustainably while continuing to implement environmentally sound business practices and manufacturing processes. Hain Celestial sells its products through specialty and natural food distributors, supermarkets, natural food stores, mass-market and e-commerce retailers, food service channels and club, drug, and convenience stores in over 75 countries worldwide. The Company operates under two reportable segments: North America and International.

*Acquisition*

On December 28, 2021, the Company acquired all outstanding stock of Proven Brands, Inc. (and its subsidiary That's How We Roll LLC) and KTB Foods Inc., collectively doing business as "That's How We Roll" ("THWR"), the producer and marketer of ParmCrisps<sup>®</sup> and Thinsters<sup>®</sup>. See Note 4, *Acquisition and Disposition,* for details.

**2.&nbsp;&nbsp;&nbsp;&nbsp;BASIS OF PRESENTATION**

The Company's unaudited consolidated financial statements include the accounts of the Company and its wholly owned and majority-owned subsidiaries. Intercompany accounts and transactions have been eliminated in consolidation. Investments in affiliated companies in which the Company exerts significant influence, but which it does not control, are accounted for under the equity method of accounting. As such, consolidated net income includes the Company's equity in the current earnings or losses of such companies.

The Company's unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States ("U.S. GAAP") for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by U.S. GAAP and should be read in conjunction with the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2022 (the "Form 10-K"). The amounts as of and for the periods ended June 30, 2022 are derived from the Company's audited annual financial statements. The unaudited consolidated financial statements reflect all normal recurring adjustments which, in management's opinion, are necessary for a fair presentation for interim periods. Operating results for the six months ended December 31, 2022 are not necessarily indicative of the results that may be expected for the fiscal year ending June 30, 2023. Please refer to the Notes to the Consolidated Financial Statements as of June 30, 2022 and for the fiscal year then ended included in the Form 10-K for information not included in these condensed notes.

All amounts in the unaudited consolidated financial statements, notes and tables have been rounded to the nearest thousand, except par values and per share amounts, unless otherwise indicated.

**Reclassifications**

Certain prior year amounts have been reclassified to conform with current year presentation.

**Significant Accounting Policies**

The Company's significant accounting policies are described in Note 2, *Summary of Significant Accounting Policies and Practices*, in the Notes to the Consolidated Financial Statements in the Form 10-K. Included herein are certain updates to those policies.

**Transfer of Financial Assets**

The Company accounts for transfers of financial assets, such as non-recourse accounts receivable financing arrangements, when the Company has surrendered control over the related assets. Determining whether control has transferred requires an evaluation of relevant legal considerations, an assessment of the nature and extent of the Company's continuing involvement with the assets

------

**<u>[Table of](#i7551ba622ce34f48a2da5a764b6c3dec_7)[Contents](#i7551ba622ce34f48a2da5a764b6c3dec_7)</u>**

transferred and any other relevant considerations. The Company has non-recourse financing arrangements in which eligible receivables are sold to third-party buyers in exchange for cash. The Company transferred accounts receivable in their entirety to the buyers and satisfied all of the conditions to report the transfer of financial assets in their entirety as a sale. The principal amount of receivables sold under these arrangements was $189,794 and $64,133 during the six months ended December 31, 2022 and 2021, respectively. The incremental cost of financing receivables under these arrangements is included in selling, general and administrative expenses on the Company's Consolidated Statements of Operations. The proceeds from the sale of receivables are included in cash used in operating activities on the Consolidated Statements of Cash Flows.

**Recently Adopted Accounting Pronouncements**

In March 2020, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2020-04, "Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting". The guidance allows for companies to: (1) account for certain contract modifications as a continuation of the existing contract without additional analysis; (2) continue hedge accounting when certain critical terms of a hedging relationship change and assess effectiveness in ways that disregard certain potential sources of ineffectiveness; and (3) make a one-time sale and/or transfer of certain debt securities from held-to-maturity to available-for-sale or trading. This ASU is available for adoption by the Company and applies prospectively to contract modifications and hedging relationships. ASU 2020-04 is currently effective and may be applied prospectively to contract modifications made on or before December 31, 2022.

In December 2022, the FASB issued ASU 2022-06, Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848, which extends the provisions of Topic 848 to December 31, 2024.

ASU 2020-04 allows for different elections to be made at different points in time and the timing of those elections will be documented as applicable. For the avoidance of doubt, the Company intends to reassess its elections of optional expedients and exceptions included within ASU 2020-04 related to its hedging activities and will document the election of these items on a quarterly basis or when changes/additions are necessary.

During fiscal year 2023, the Company adopted hedge accounting expedients related to probability of forecasted transactions to assert probability of the hedged interest (payments/receipts) regardless of any expected modification in terms related to reference rate reform. The Company has also adopted the Secured Overnight Financing Rate ("SOFR") as the alternative reference rate to replace LIBOR with respect to the Company's long-term debt. Application of these expedients preserves the presentation of derivatives consistent with past presentation. The Company is continuing to assess the impact of the guidance and may apply other elections as applicable as additional changes in the market occur.

**3.&nbsp;&nbsp;&nbsp;&nbsp;EARNINGS PER SHARE**

The following table sets forth the computation of basic and diluted net income per share utilized to calculate earnings per share on the Consolidated Statements of Operations:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended December 31,** | **Three Months Ended December 31,** | **Six Months Ended December 31,** | **Six Months Ended December 31,** |
|  | **2022** | **2021** | **2022** | **2021** |
| Numerator: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income | $10966 | $30889 | $17889 | $50300 |
| Denominator: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic weighted average shares outstanding  | 89380 | 94036 | 89343 | 95579 |
| &nbsp;&nbsp;&nbsp;&nbsp;Effect of dilutive stock options, unvested restricted stock and unvested restricted share units | 198 | 772 | 192 | 544 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted weighted average shares outstanding | 89578 | 94808 | 89535 | 96123 |

---

There were 372 and 316 restricted stock awards excluded from our calculation of diluted net income per share for the three months ended December 31, 2022 and 2021, respectively, as such awards were anti-dilutive. There were 453 and 158 stock-based awards comprised of restricted stock awards and stock options excluded from the calculation of diluted net income per share for the six months ended December 31, 2022 and 2021, respectively, as such awards were anti-dilutive.

------

**<u>[Table of](#i7551ba622ce34f48a2da5a764b6c3dec_7)[Contents](#i7551ba622ce34f48a2da5a764b6c3dec_7)</u>**

Additionally, 401 and 76 stock-based awards outstanding at December 31, 2022 and 2021, respectively, were excluded from the calculation of diluted net income per share for the three months ended December 31, 2022 and 2021, respectively, as such awards were contingently issuable based on market or performance conditions, and such conditions had not been achieved during the respective periods. Furthermore, 286 and 76 stock-based awards outstanding at December 31, 2022 and 2021, respectively, were excluded from the calculation of diluted net income per share for the six months ended December 31, 2022 and 2021, respectively, as such awards were contingently issuable based on market or performance conditions, and such conditions had not been achieved during the respective periods.

*Share Repurchase Program*

In January 2022, the Company's Board of Directors (the "Board") authorized the repurchase of up to $200,000 of the Company's issued and outstanding common stock. Repurchases may be made from time to time in the open market, pursuant to pre-set trading plans, in private transactions or otherwise. The current authorization does not have a stated expiration date. The extent to which the Company repurchases its shares and the timing of such repurchases will depend upon market conditions and other corporate considerations. During the six months ended December 31, 2022, the Company did not repurchase any shares under the repurchase program. As of December 31, 2022, the Company had $173,514 of remaining authorization under the share repurchase program. During the six months ended December 31, 2021, the Company repurchased 6,552 shares under the repurchase program for a total of $265,420 excluding commissions, at an average price of $40.50 per share. Repurchases made during the six months ended December 31, 2021, were made under a previous Board authorization.

**4. &nbsp;&nbsp;&nbsp;&nbsp;ACQUISITION AND DISPOSITION**

***<u>Acquisition</u>***

***That's How We Roll***

On December 28, 2021, the Company acquired all outstanding stock of THWR, the producer and marketer of ParmCrisps<sup>®</sup> and Thinsters<sup>®</sup>, deepening the Company's position in the snacking category. Consideration for the transaction consisted of cash, net of cash acquired, totaling $260,185. Of the total consideration, $259,985 was paid with the remaining $200 payable as of December 31, 2022. The acquisition was funded with borrowings under the Credit Agreement (as defined in Note 9, *Debt and Borrowings*).

During the three months ended December 31, 2022 the Company finalized the purchase price allocation and recognized a measurement period adjustment of $794 to acquired deferred tax assets, with a related impact to goodwill. Results of THWR are included in the United States operating segment, a component of the North America reportable segment. THWR's net sales included in our consolidated results were 3.5% of consolidated net sales for the three and six months ended December 31, 2022.

The following table provides unaudited pro forma results of operations had the acquisition been completed at the beginning of fiscal 2022. The pro forma information reflects certain adjustments related to the acquisition but does not reflect any potential operating efficiencies or cost savings that may result from the acquisition. Accordingly, this information has been provided for illustrative purposes only and does not purport to be indicative of the actual results that would have been achieved by the Company for the periods presented or that will be achieved by the combined company in the future. The pro forma information has been adjusted to give effect to items that are directly attributable to the transactions and are expected to have a continuing impact on the combined results.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Unaudited supplemental pro forma information** | **Unaudited supplemental pro forma information** | **Unaudited supplemental pro forma information** | **Unaudited supplemental pro forma information** |
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
| | **December 31, 2022** | **December 31, 2021** | **December 31, 2022** | **December 31, 2021** |
| Net sales | $454208 | $500349 | $893559 | $985544 |
| Net income from operations | $10966 | $36244 | $17889 | $55669 |
| Diluted net income per common share from operations | $0.12 | $0.38 | $0.20 | $0.58 |

---

------

**<u>[Table of](#i7551ba622ce34f48a2da5a764b6c3dec_7)[Contents](#i7551ba622ce34f48a2da5a764b6c3dec_7)</u>**

The Company's acquisition is described in more detail in Note 4, *Acquisitions and Dispositions*, in the Notes to the Consolidated Financial Statements in the Form 10-K.

***<u>Disposition</u>***

***Westbrae Natural***<sup>®</sup>

On December 15, 2022, the Company completed the divestiture of its Westbrae Natural<sup>®</sup> brand ("Westbrae") for total cash consideration of $7,498. The sale of Westbrae is consistent with the Company's portfolio simplification process. Westbrae operated out of the United States and was part of the Company's North America reportable segment. During the three months ended December 31, 2022, the Company deconsolidated the net assets of Westbrae, primarily consisting of $3,054 of goodwill, and recognized a pre-tax gain on sale of $3,359.

**5.&nbsp;&nbsp;&nbsp;&nbsp;INVENTORIES**

Inventories consisted of the following:

---

| | | |
|:---|:---|:---|
| | **December 31,<br>2022** | **June 30,<br>2022** |
| Finished goods | $194071 | $202544 |
| Raw materials, work-in-progress and packaging | 130454 | 105490 |
|  | $324525 | $308034 |

---

------

**<u>[Table of](#i7551ba622ce34f48a2da5a764b6c3dec_7)[Contents](#i7551ba622ce34f48a2da5a764b6c3dec_7)</u>**

**6.&nbsp;&nbsp;&nbsp;&nbsp;PROPERTY, PLANT AND EQUIPMENT, NET**

Property, plant and equipment, net consisted of the following:

---

| | | |
|:---|:---|:---|
| | **December 31,<br>2022** | **June 30,<br>2022** |
| Land | $11177 | $11216 |
| Buildings and improvements | 50150 | 51849 |
| Machinery and equipment | 301240 | 296398 |
| Computer hardware and software | 64319 | 65680 |
| Furniture and fixtures | 21548 | 23522 |
| Leasehold improvements | 53753 | 54999 |
| Construction in progress | 40399 | 27200 |
|  | 542586 | 530864 |
| Less: Accumulated depreciation and impairment | 247951 | 233459 |
|  | $294635 | $297405 |

---

Depreciation expense for the three months ended December 31, 2022 and 2021 was $8,195 and $7,244, respectively. Depreciation expense for the six months ended December 31, 2022 and 2021 was $16,262 and $14,652, respectively.

The Company recognized an impairment charge of $340 during the three months ended December 31, 2022 relating to a facility in the United States that is held for sale. The facility had a net carrying value of $1,500 and $1,840 as of December 31, 2022 and June 30, 2022 respectively.

**7.&nbsp;&nbsp;&nbsp;&nbsp;LEASES**

The Company leases office space, warehouse and distribution facilities, manufacturing equipment and vehicles primarily in North America and Europe. The Company determines if an arrangement is or contains a lease at inception. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. The Company's lease agreements generally do not contain residual value guarantees or material restrictive covenants.

Some of the Company's leases contain variable lease payments, which are expensed as incurred unless those payments are based on an index or rate. Variable lease payments based on an index or rate are initially measured using the index or rate in effect at lease commencement and included in the measurement of the lease liability; thereafter, changes to lease payments due to rate or index changes are recorded as variable lease expense in the period incurred. The Company does not have any related party leases, and sublease transactions are de minimis.

------

**<u>[Table of](#i7551ba622ce34f48a2da5a764b6c3dec_7)[Contents](#i7551ba622ce34f48a2da5a764b6c3dec_7)</u>**

The components of lease expenses for the three and six months ended December 31, 2022 were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
| | **December 31, 2022** | **December 31, 2021** | **December 31, 2022** | **December 31, 2021** |
| Operating lease expenses | $2238 | $3665 | $7213 | $7417 |
| Finance lease expenses | 71 | 67 | 140 | 137 |
| Variable lease expenses | 169 | 306 | 349 | 709 |
| Short-term lease expenses | 390 | 677 | 886 | 2042 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total lease expenses | $2868 | $4715 | $8588 | $10305 |

---

Supplemental balance sheet information related to leases was as follows:

---

| | | | |
|:---|:---|:---|:---|
| **Leases** | **Classification** | **December 31, 2022** | **June 30, 2022** |
| Assets |  |  |  |
| &nbsp;&nbsp;&nbsp;Operating lease ROU assets, net | Operating lease right-of-use assets, net | $101374 | $114691 |
| &nbsp;&nbsp;&nbsp;Finance lease ROU assets, net | Property, plant and equipment, net | 366 | 413 |
| Total leased assets |  | $101740 | $115104 |
| Liabilities |  |  |  |
| &nbsp;&nbsp;&nbsp;Current |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating | Accrued expenses and other current liabilities | $13448 | $13154 |
| &nbsp;&nbsp;&nbsp;&nbsp;Finance | Current portion of long-term debt | 100 | 149 |
| &nbsp;&nbsp;&nbsp;Non-current |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating | Operating lease liabilities, noncurrent portion | 92587 | 107481 |
| &nbsp;&nbsp;&nbsp;&nbsp;Finance | Long-term debt, less current portion | 279 | 278 |
| Total lease liabilities |  | $106414 | $121062 |

---

Additional information related to leases is as follows:

---

| | | |
|:---|:---|:---|
| | **Six Months Ended** | **Six Months Ended** |
| | **December 31, 2022** | **December 31, 2021** |
| **Supplemental cash flow information** | | |
| **Cash paid for amounts included in the measurement of lease liabilities:** | | |
| Operating cash flows from operating leases | $8173 | $7560 |
| Operating cash flows from finance leases | $9 | $10 |
| Financing cash flows from finance leases | $106 | $123 |
| **ROU assets obtained in exchange for lease obligations:** |  |  |
| Operating leases<sup>(1)</sup> | $(4764) | $3182 |
| Finance leases | $60 | $116 |
| **ROU assets obtained in connection with an acquisition:** |  |  |
| Operating leases | $— | $4098 |
| **Weighted average remaining lease term:** |  |  |
| Operating leases | 10.7 years | 9.5 years |
| Finance leases | 4.1 years | 4.2 years |
| **Weighted average discount rate:** |  |  |
| Operating leases | 4.7% | 3.2% |
| Finance leases | 4.6% | 3.9% |

---

------

**<u>[Table of](#i7551ba622ce34f48a2da5a764b6c3dec_7)[Contents](#i7551ba622ce34f48a2da5a764b6c3dec_7)</u>**

<sup>(1)</sup> *Includes adjustment for modification of an operating lease during the three months ended December 31, 2022 which resulted in a reduction of ROU assets and lease liabilities of $13,876 and $17,244 respectively, and recognition of a gain of $3,368 related to the modification.*

Maturities of lease liabilities as of December 31, 2022 were as follows:

---

| | | | |
|:---|:---|:---|:---|
| **Fiscal Year** | **Operating leases** | **Finance leases** | **Total** |
| 2023 (remainder of year) | $9544 | $64 | $9608 |
| 2024 | 14842 | 101 | 14943 |
| 2025 | 12564 | 99 | 12663 |
| 2026 | 11919 | 74 | 11993 |
| 2027 | 11638 | 54 | 11692 |
| Thereafter | 77290 | 25 | 77315 |
| &nbsp;&nbsp;&nbsp;Total lease payments | 137797 | 417 | 138214 |
| Less: Imputed interest | 31762 | 38 | 31800 |
| &nbsp;&nbsp;&nbsp;Total lease liabilities | $106035 | $379 | $106414 |

---

**8.&nbsp;&nbsp;&nbsp;&nbsp;GOODWILL AND OTHER INTANGIBLE ASSETS** 

***Goodwill***

The following table provides changes in the carrying value of goodwill by reportable segment:

---

| | | | |
|:---|:---|:---|:---|
| | **North America** | **International** | **Total** |
| Balance as of June 30, 2022 | $695715 | $238081 | $933796 |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition<sup>(1)</sup> | (794) |  | (794) |
| &nbsp;&nbsp;&nbsp;&nbsp;Divestiture<sup>(2)</sup> | (3054) |  | (3054) |
| &nbsp;&nbsp;&nbsp;&nbsp;Translation and other adjustments, net | 4252 | (7122) | (2870) |
| Balance as of December 31, 2022 | $696119 | $230959 | $927078 |

---

<sup>(1)</sup> *During the second quarter of fiscal year 2023, the Company finalized purchase accounting related to THWR resulting in a $794 reduction to goodwill. See Note 4.*

<sup>(2)</sup> *During December 2022, the Company completed the divestiture of Westbrae, a component of the United States reporting unit. Goodwill of $3,054 was assigned to the divested businesses on a relative fair value basis.*

***Other Intangible Assets***

The following table includes the gross carrying amount and accumulated amortization, where applicable, for intangible assets, excluding goodwill:

---

| | | |
|:---|:---|:---|
| | **December 31,<br>2022** | **June 30,<br>2022** |
| Non-amortized intangible assets: |  |  |
| &nbsp;&nbsp;&nbsp;Trademarks and tradenames | $374772 | $379466 |
| Amortized intangible assets: |  |  |
| &nbsp;&nbsp;&nbsp;Other intangibles | 202802 | 199448 |
| &nbsp;&nbsp;&nbsp;Less: Accumulated amortization | (106618) | (101381) |
| &nbsp;&nbsp;&nbsp;Net amortized intangible assets | 96184 | 98067 |
| Net other intangible assets | $470956 | $477533 |

---

There were no events or circumstances that warranted an interim impairment test for indefinite-lived intangible assets during the three and six months ended December 31, 2022 or 2021.

------

**<u>[Table of](#i7551ba622ce34f48a2da5a764b6c3dec_7)[Contents](#i7551ba622ce34f48a2da5a764b6c3dec_7)</u>**

Amortized intangible assets, which are deemed to have a finite life, primarily consist of customer relationships, trademarks and tradenames and are amortized over their estimated useful lives of 7 to 25 years. Amortization expense included in the Consolidated Statements of Operations was as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended December 31,** | **Three Months Ended December 31,** | **Six Months Ended December 31,** | **Six Months Ended December 31,** |
| | **2022** | **2021** | **2022** | **2021** |
| Amortization of acquired intangibles | $2785 | $2050 | $5573 | $4145 |

---

**9.&nbsp;&nbsp;&nbsp;&nbsp;DEBT AND BORROWINGS**

Debt and borrowings consisted of the following:

---

| | | |
|:---|:---|:---|
| | **December 31,<br>2022** | **June 30,<br>2022** |
| Revolving credit facility | $587000 | $593000 |
| Term loans | 292500 | 296250 |
| Less: Unamortized issuance costs | (1495) | (1105) |
| Other borrowings<sup>(1)</sup> | 397 | 498 |
|  | 878402 | 888643 |
| Short-term borrowings and current portion of long-term debt<sup>(2)</sup> | 7602 | 7705 |
| Long-term debt, less current portion | $870800 | $880938 |

---

<sup>(1)</sup> *Includes $379 (June 30, 2022: $427) of finance lease obligations as discussed in Note 7, Leases.*

<sup>(2)</sup> *Includes $100 (June 30, 2022: $149) of short-term finance lease obligations as discussed in Note 7, Leases.*

***Amended and Restated Credit Agreement***

On December 22, 2021, the Company refinanced its revolving credit facility by entering into a Fourth Amended and Restated Credit Agreement (as amended by a First Amendment dated December 16, 2022, the "Credit Agreement"). The Credit Agreement provides for senior secured financing of $1,100,000 in the aggregate, consisting of (1) $300,000 in aggregate principal amount of term loans (the "Term Loans") and (2) an $800,000 senior secured revolving credit facility (which includes borrowing capacity available for letters of credit and is comprised of a $440,000 U.S. revolving credit facility and $360,000 global revolving credit facility) (the "Revolver"). Both the Revolver and the Term Loans mature on December 22, 2026.

The Credit Agreement includes financial covenants that require compliance with a consolidated interest coverage ratio, a consolidated leverage ratio and a consolidated secured leverage ratio. The minimum consolidated interest coverage ratio is 2.75:1.00. The maximum consolidated leverage ratio is 6.00:1.00. Through December 31, 2023 or such earlier date as elected by the Company (the "Amendment Period"), the maximum consolidated secured leverage ratio is 5.00:1.00. Following the Amendment Period, the maximum consolidated secured leverage ratio will be 4.25:1.00, subject to possible temporary increase following certain corporate acquisitions.

During the Amendment Period, loans under the Credit Agreement will bear interest at (a) the Secured Overnight Financing Rate, plus a credit spread adjustment of 0.10% (as adjusted, "Term SOFR") plus 2.0% per annum or (b) the Base Rate (as defined in the Credit Agreement) plus 1.0% per annum. Following the Amendment Period, loans will bear interest at rates based on (a) Term SOFR plus a rate ranging from 0.875% to 1.750% per annum or (b) the Base Rate plus a rate ranging from 0.00% to 0.750% per annum, the relevant rate in each case being the Applicable Rate. The Applicable Rate following the Amendment Period will be determined in accordance with a leverage-based pricing grid, as set forth in the Credit Agreement. The weighted average interest rate on outstanding borrowings under the Credit Agreement at December 31, 2022 was 5.59%. Additionally, the Credit Agreement contains a Commitment Fee (as defined in the Credit Agreement) on the amount unused under the Credit Agreement ranging from 0.15% to 0.25% per annum, and such Commitment Fee is determined in accordance with a leverage-based pricing grid.

As of December 31, 2022, there were $587,000 of loans under the Revolver, $292,500 of Term Loans, and $6,769 of letters of credit outstanding under the Credit Agreement. As of December 31, 2022, $206,231 was available under the Credit Agreement, subject to compliance with the financial covenants. As of December 31, 2022, the Company was in compliance with all associated covenants.

------

**<u>[Table of](#i7551ba622ce34f48a2da5a764b6c3dec_7)[Contents](#i7551ba622ce34f48a2da5a764b6c3dec_7)</u>**

*Credit Agreement Issuance Costs*

In connection with the First Amendment to its Credit Agreement during the second quarter of fiscal year 2023, the Company incurred debt issuance costs of approximately $1,987, of which $1,916 was deferred. Of the total deferred costs, $1,396 were associated with the Revolver and are being amortized on a straight-line basis within Other assets on our Consolidated Balance Sheets, and $520 are being amortized on a straight-line basis, which approximates the effective interest method, as an adjustment to the carrying amount of the Term Loans as a component of Interest and other financing expense, net over the term of the Credit Agreement.

Maturities of all debt instruments at December 31, 2022, are as follows:

---

| | |
|:---|:---|
| **Due in Fiscal Year** | **Amount** |
| Remainder of 2023 | $3729 |
| 2024 | 7361 |
| 2025 | 7343 |
| 2026 | 7320 |
| 2027 | 852649 |
| Total debt and borrowings | $878402 |

---

**10.&nbsp;&nbsp;&nbsp;&nbsp;INCOME TAXES** 

In general, the Company uses an estimated annual effective tax rate, which is based on expected annual income and statutory tax rates in the various jurisdictions in which the Company operates, to determine its quarterly provision for income taxes. Certain significant or unusual items are separately recognized in the quarter in which they occur and can be a source of variability on the effective tax rates from quarter to quarter. The Company's effective tax rate may change from period-to-period based on recurring and non-recurring factors including the geographical mix of earnings, enacted tax legislation, state and local income taxes and tax audit settlements.

The effective income tax rate was an expense of 36.0% and 18.6% for the three months ended December 31, 2022 and 2021, respectively. The effective income tax rate was an expense of 32.6% and 18.6% for the six months ended December 31, 2022 and 2021, respectively. The effective income tax rate for the six months ended December 31, 2022 was impacted by the gain on the sale of Westbrae, an operating lease modification during the second quarter, severance with respect to our former CEO (as part of the limitation on the deductibility of executive compensation), stock-based compensation and uncertain tax positions. The effective income tax rate for the six months ended December 31, 2021 was impacted by the reversal of uncertain tax position accruals based on filing of certain elections by taxing authorities, deductions related to stock-based compensation, non-deductible transaction costs related to the acquisition of THWR, and the reversal of a valuation allowance due to the utilization of a capital loss carryover. The effective income tax rates in each period were also impacted by the geographical mix of earnings and state income taxes.

------

**<u>[Table of](#i7551ba622ce34f48a2da5a764b6c3dec_7)[Contents](#i7551ba622ce34f48a2da5a764b6c3dec_7)</u>**

**11. &nbsp;&nbsp;&nbsp;&nbsp;ACCUMULATED OTHER COMPREHENSIVE LOSS**

The following table presents the changes in accumulated other comprehensive loss (AOCL):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended December 31,** | **Three Months Ended December 31,** | **Six Months Ended December 31,** | **Six Months Ended December 31,** |
| | **2022** | **2021** | **2022** | **2021** |
| Foreign currency translation adjustments: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Other comprehensive income (loss) income before reclassifications | $59674 | $(2143) | $(7476) | $(24948) |
| Deferred (losses) gains on cash flow hedging instruments: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Amount of (loss) gain recognized in AOCL on derivatives <sup>(1)</sup> | (454) | 1002 | 10907 | 1537 |
| &nbsp;&nbsp;&nbsp;Amount of gain reclassified from AOCL into income <sup>(1)</sup> | (1411) | (464) | (2180) | (964) |
| Deferred (losses) gains on fair value hedging instruments: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Amount of (loss) gain recognized in AOCL on derivatives <sup>(1)</sup> | (1067) |  | 78 |  |
| &nbsp;&nbsp;&nbsp;Amount of loss reclassified from AOCL into expense <sup>(1)</sup> | 1588 |  | 240 |  |
| Deferred (losses) gains on net investment hedging instruments: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Amount of (loss) gain recognized in AOCL on derivatives <sup>(1)</sup> | (4359) | 1460 | 309 | 3370 |
| &nbsp;&nbsp;&nbsp;Amount of gain reclassified from AOCL into income <sup>(1)</sup> | (373) | (111) | (742) | (214) |
| Net change in AOCL | $53598 | $(256) | $1136 | $(21219) |

---

<sup>(1)</sup> *See Note 15, Derivatives and Hedging Activities, for the amounts reclassified into income for deferred gains (losses) on cash flow hedging instruments recorded in the Consolidated Statements of Operations in the three and six months ended December 31, 2022 and 2021.*

------

**<u>[Table of](#i7551ba622ce34f48a2da5a764b6c3dec_7)[Contents](#i7551ba622ce34f48a2da5a764b6c3dec_7)</u>**

**12.&nbsp;&nbsp;&nbsp;&nbsp;STOCK-BASED COMPENSATION AND INCENTIVE PERFORMANCE PLANS** 

Under the Company's Amended and Restated 2002 Long-Term Incentive and Stock Award Plan (the "2002 Plan"), the Company historically granted equity-based awards to its officers, senior management, other key employees, consultants, and directors. The Company currently utilizes a stockholder-approved plan, The Hain Celestial Group, Inc. 2022 Long Term Incentive and Stock Award Plan (the "2022 Plan") which was approved at the Company's 2022 Annual Meeting of Stockholders held on November 17, 2022. The 2022 Plan permits the Company to continue making equity-based and other incentive awards in a manner intended to properly incentivize its employees, directors, consultants and other service providers by aligning their interests with the interests of the Company's stockholders. The Company also historically granted shares under its 2019 Equity Inducement Award Program (the "2019 Inducement Program") to induce selected individuals to become employees of the Company. The 2002 Plan, the 2022 Plan and the 2019 Inducement Program are collectively referred to as the "Stock Award Plans." In conjunction with the Stock Award Plans, the Company maintains a long-term incentive program (the "LTI Program" or "LTIP") that provides for equity awards, including performance and market-based equity awards that can be earned over defined performance periods. The Company's LTIP plans, with the exception of the 2023 - 2025 LTIP described below, are described in Note 13, *Stock-Based Compensation and Incentive Performance Plans*, in the Notes to the Consolidated Financial Statements in the Form 10-K.

Compensation cost and related income tax benefits recognized in the Consolidated Statements of Operations for stock-based compensation plans were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended December 31,** | **Three Months Ended December 31,** | **Six Months Ended December 31,** | **Six Months Ended December 31,** |
| | **2022** | **2021** | **2022** | **2021** |
| Selling, general and administrative expense | $3435 | $4156 | $7429 | $8443 |
| Related income tax benefit | $552 | $434 | $954 | $707 |

---

***Restricted Stock***

Awards of restricted stock are either restricted stock awards ("RSAs") or restricted stock units ("RSUs") that are issued at no cost to the recipient. Performance-based or market-based RSUs are issued in the form of performance share units ("PSUs"). A summary of the restricted stock activity (including all RSAs, RSUs and PSUs) for the six months ended December 31, 2022 is as follows:

---

| | | |
|:---|:---|:---|
| | Number of Shares<br>and Units | Weighted<br>Average Grant<br>Date Fair <br>Value (per share) |
| Non-vested RSAs, RSUs and PSUs outstanding at June 30, 2022 | 790 | $42.44 |
| Granted | 1003 | $21.39 |
| Vested | (166) | $39.20 |
| Forfeited | (335) | $37.28 |
| Non-vested RSAs, RSUs and PSUs outstanding at December 31, 2022 | 1292 | $29.37 |

---

The table above includes a total of 299 shares granted during the six months ended December 31, 2022 that represent the target number of shares that may be earned based on pre-defined market conditions that are eligible to vest ranging from zero to 200% of target. All such shares relate to the 2023 – 2025 LTIP as further described below. Vested shares during the six months ended December 31, 2022 include a total of 5 shares related to certain performance-based metrics being met and a total of 161 shares related to service-based RSUs. There are market-based PSU awards outstanding under both the 2023 – 2025 LTIP and the 2022 – 2024 LTIP. At December 31, 2022, 299 of such shares were outstanding under the 2023 – 2025 LTIP while 82 shares were outstanding under the 2022 – 2024 LTIP.

The fair value of RSAs, RSUs and PSUs granted and of shares vested, and the tax benefit recognized from restricted shares vesting was as follows:

------

**<u>[Table of](#i7551ba622ce34f48a2da5a764b6c3dec_7)[Contents](#i7551ba622ce34f48a2da5a764b6c3dec_7)</u>**

---

| | | |
|:---|:---|:---|
| | **Six Months Ended December 31,** | **Six Months Ended December 31,** |
| | **2022** | **2021** |
| Fair value of RSAs, RSUs and PSUs granted | $21457 | $34678 |
| Fair value of shares vested | $3317 | $68017 |
| Tax benefit recognized from restricted shares vesting | $502 | $3532 |

---

At December 31, 2022, there was $26,765 of unrecognized stock-based compensation expense related to non-vested restricted stock awards which is expected to be recognized over a weighted average period of 2.0 years.

*2023-2025 LTIP*

During the six months ended December 31, 2022, the Company granted market-based PSU awards under the LTI Program with a total target payout of 299 shares of common stock. Such PSU awards (the "Absolute TSR PSUs") will vest, if at all, pursuant to a defined calculation of either relative TSR or absolute TSR (as defined) over the period from September 6, 2022 through the earlier of (i) September 6, 2025; (ii) the date the participant's employment is terminated due to death or Disability (as defined); or (iii) the effective date of a Change in Control (as defined) (the "TSR Performance Period"). Vesting of 200 target shares of the outstanding PSU awards is pursuant to a defined calculation of relative TSR over the TSR Performance Period (the "Relative TSR PSUs"). Vesting of 99 target shares of the outstanding PSU awards is pursuant to the achievement of pre-established three-year compound annual TSR targets over the TSR Performance Period (the "Absolute TSR PSUs"). Total shares eligible to vest for both the Relative TSR PSUs and Absolute TSR PSUs range from zero to 200% of the target amount. Grant date fair values are calculated using a Monte-Carlo simulation model with grant date fair values per target share and related valuation assumptions as follows:

---

| | | |
|:---|:---|:---|
| | **Absolute TSR PSUs** | **Relative TSR PSUs** |
| Grant date fair value (per target share) | $20.18 | $27.47 |
| Risk-free interest rate | 3.54% | 3.54% |
| Expected dividend yield |  |  |
| Expected volatility | 40.30% | 26.60% |
| Expected term | 3.00 years | 3.00 years |

---

*CEO Succession*

On November 22, 2022, the Board approved a succession plan pursuant to which Mark L. Schiller transitioned from his position as President and Chief Executive Officer of the Company effective as of December 31, 2022 (the "Transition Date"). Mr. Schiller remains a director on the Board following the Transition Date. As of the Transition Date, certain of Mr. Schiller's stock-based compensation awards were modified and others were forfeited. Additionally, Mr. Schiller will receive severance totaling $4,725, paid in installments over a two-year period following the Transition Date. Severance, including payroll taxes and other costs, was recognized during the three months ended December 31, 2022, and is accrued at December 31, 2022. The Board appointed Wendy P. Davidson to the role of President and Chief Executive Officer and as a director on the Board, in each case effective as of January 1, 2023 (the "Start Date").

On the Start Date, Ms. Davidson received the following awards under the 2023-2025 LTIP: 36 Relative TSR PSUs (at target), 18 Absolute TSR PSUs (at target) and 36 RSUs. The Relative TSR PSUs and Absolute TSR PSUs have the same TSR Performance Period, performance goals and beginning stock price as those applicable to awards granted to other employees under the 2023-2025 LTIP. The RSUs will vest in one-third (1/3) installments on each of September 6, 2023, 2024 and 2025. Additionally, in recognition of the compensation Ms. Davidson forfeited by leaving her former employer, on the Start Date Ms. Davidson also received a one-time make-whole RSU award of 95 RSUs that will vest in one-third (1/3) installments on each of the first, second and third anniversaries of the Start Date.

------

**<u>[Table of](#i7551ba622ce34f48a2da5a764b6c3dec_7)[Contents](#i7551ba622ce34f48a2da5a764b6c3dec_7)</u>**

**13.&nbsp;&nbsp;&nbsp;&nbsp;INVESTMENTS** 

On October 27, 2015, the Company acquired a minority equity interest in Chop't Creative Salad Company LLC, predecessor to Founders Table Restaurant Group, LLC ("Founders Table"). Founders Table owns and operates the fast-casual restaurant chains Chop't Creative Salad Co. and Dos Toros Taqueria. The investment is being accounted for as an equity method investment due to the Company's representation on the Board of Directors of Founders Table. At December 31, 2022 and June 30, 2022, the carrying value of the Company's investment in Founders Table was $8,288 and $9,491, respectively, and is included in the Consolidated Balance Sheets as a component of Investments and joint ventures.

The Company also holds an investment in Hutchison Hain Organic Holdings Limited, a joint venture with HUTCHMED (China) Limited, accounted for under the equity method of accounting. The carrying value of the remaining investments were $4,972 and $4,965 as of December 31, 2022 and June 30, 2022, respectively, and is included in the Consolidated Balance Sheets as a component of Investments and joint ventures.

**14.&nbsp;&nbsp;&nbsp;&nbsp;FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE**

The Company's financial assets and liabilities measured at fair value are required to be grouped in one of three levels. The levels prioritize the inputs used to measure the fair value of the assets or liabilities. These levels are:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 2 – Quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 3 – Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e., supported by little or no market activity).

The following table presents assets and liabilities measured at fair value on a recurring basis as of December 31, 2022:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Total | Quoted<br>prices in<br>active<br>markets<br>(Level 1) | Significant<br>other<br>observable<br>inputs<br>(Level 2) | Significant<br>unobservable<br>inputs<br>(Level 3) |
| Assets: |  |  |  |  |
| Derivative financial instruments | $15101 | $— | $15101 | $— |
| Equity investment | 2 | 2 |  |  |
| Total | $15103 | $2 | $15101 | $— |

---

The following table presents assets and liabilities measured at fair value on a recurring basis as of June 30, 2022:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Total | Quoted<br>prices in<br>active<br>markets<br>(Level 1) | Significant<br>other<br>observable<br>inputs<br>(Level 2) | Significant<br>unobservable<br>inputs<br>(Level 3) |
| Assets: |  |  |  |  |
| Derivative financial instruments | $7476 | $— | $7476 | $— |
| Equity investment | 560 | 560 |  |  |
| Total | $8036 | $560 | $7476 | $— |
| Liabilities: |  |  |  |  |
| Derivative financial instruments | 3184 |  | 3184 |  |
| Total | $3184 | $— | $3184 | $— |

---

There were no transfers of financial instruments between the three levels of fair value hierarchy during the six months ended December 31, 2022 or 2021.

------

**<u>[Table of](#i7551ba622ce34f48a2da5a764b6c3dec_7)[Contents](#i7551ba622ce34f48a2da5a764b6c3dec_7)</u>**

***Derivative Instruments***

The Company uses interest rate swaps to manage its interest rate risk and cross-currency swaps and foreign currency exchange contracts to manage its exposure to fluctuations in foreign currency exchange rates. The valuation of these instruments is determined using widely accepted valuation techniques, including discounted cash flow analysis on the expected cash flows of each derivative. This analysis reflects the contractual terms of the derivatives, including the period to maturity, and uses observable market-based inputs, including interest rate curves and implied volatilities. The fair values of interest rate swaps are determined using the market standard methodology of netting the discounted future fixed cash receipts (or payments) and the discounted expected variable cash payments (or receipts). The variable cash payments (or receipts) are based on an expectation of future interest rates (forward curves) derived from observable market interest rate curves.

The Company incorporates credit valuation adjustments to appropriately reflect both the Company's nonperformance risk and the respective counterparty's nonperformance risk in the fair value measurements. In adjusting the fair value of the Company's derivative contracts for the effect of nonperformance risk, the Company has considered the impact of netting and any applicable credit enhancements, such as collateral postings, thresholds, mutual puts and guarantees.

Although the Company has determined that the majority of the inputs used to value its derivatives fall within Level 2 of the fair value hierarchy, the credit valuation adjustments associated with its derivatives utilize Level 3 inputs, such as estimates of current credit spreads to evaluate the likelihood of default by the Company and its counterparties. The Company has determined that the significance of the impact of the credit valuation adjustments made to its derivative contracts, which determination was based on the fair value of each individual contract, was not significant to the overall valuation. As a result, all of the derivatives held as of December 31, 2022 and June 30, 2022 were classified as Level 2 of the fair value hierarchy.

**15.&nbsp;&nbsp;&nbsp;&nbsp;DERIVATIVES AND HEDGING ACTIVITIES**

**Risk Management Objective of Using Derivatives**

The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company manages its exposures to a wide variety of business and operational risks. The Company manages economic risks, including interest rate, liquidity, and credit risk primarily by managing the amount, sources and duration of its assets and liabilities and the use of derivative financial instruments. Specifically, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the value of which are determined by interest rates. The Company's derivative financial instruments are used to manage differences in the amount, timing, and duration of the Company's known or expected cash receipts and its known or expected cash payments principally related to the Company's receivables and borrowings.

Certain of the Company's foreign operations expose the Company to fluctuations of foreign exchange rates. These fluctuations may impact the value of the Company's cash receipts and payments in terms of the Company's functional currency. The Company enters into derivative financial instruments to protect the value or fix the amount of certain assets and liabilities in terms of its functional currency, the U.S. Dollar.

Accordingly, the Company uses derivative financial instruments to manage and mitigate such risks. The Company does not use derivatives for speculative or trading purposes.

***Cash Flow Hedges of Interest Rate Risk***

The Company's objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. During the three and six months ended December 31, 2022, such derivatives were used to hedge the variable cash flows associated with existing variable rate debt.

For derivatives designated and that qualify as cash flow hedges of interest rate risk, the gain or loss on the derivative is recorded in AOCL and subsequently reclassified into interest expense in the same period during which the hedged transaction affects earnings. Amounts reported in AOCL related to derivatives will be reclassified to interest expense as interest payments are made on the Company's variable rate debt. During the remaining six months of fiscal 2023, the Company estimates that an additional $3,664 will be reclassified as a decrease to interest expense.

------

**<u>[Table of](#i7551ba622ce34f48a2da5a764b6c3dec_7)[Contents](#i7551ba622ce34f48a2da5a764b6c3dec_7)</u>**

As of December 31, 2022, the Company had the following outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk:

---

| | | |
|:---|:---|:---|
| **Interest Rate Derivative** | **Number of Instruments** | **Notional Amount** |
| Interest Rate Swap | 8 | $630000 |

---

***Cash Flow Hedges of Foreign Exchange Risk***

The Company is exposed to fluctuations in various foreign currencies against its functional currency, the U.S. Dollar. The Company uses foreign currency derivatives including cross-currency swaps to manage its exposure to fluctuations in the USD-EUR exchange rates. Cross-currency swaps involve exchanging fixed-rate interest payments for fixed-rate interest receipts, both of which will occur at the USD-EUR forward exchange rates in effect upon entering into the instrument. The Company, at times, also uses forward contracts to manage its exposure to fluctuations in the GBP-EUR exchange rates. The Company designates these derivatives as cash flow hedges of foreign exchange risks.

For derivatives designated and that qualify as cash flow hedges of foreign exchange risk, the gain or loss on the derivative is recorded in AOCL and subsequently reclassified in the period(s) during which the hedged transaction affects earnings within the same income statement line item as the earnings effect of the hedged transaction. During the remaining six months of fiscal 2023, the Company estimates that an additional $46 relating to cross-currency swaps will be reclassified as an increase to interest expense.

As of December 31, 2022, the Company had the following outstanding foreign currency derivatives that were used to hedge its foreign exchange risks:

---

| | | | |
|:---|:---|:---|:---|
| **Foreign Currency Derivative** | **Number of Instruments** | **Notional Sold** | **Notional Purchased** |
| Foreign currency forward contract | 3 | £2,590 | €3,000 |

---

***Net Investment Hedges***

The Company is exposed to fluctuations in foreign exchange rates on investments it holds in its European foreign entities and their exposure to the Euro. The Company uses fixed-to-fixed cross-currency swaps to hedge its exposure to changes in the foreign exchange rate on its foreign investment in Europe. Currency forward agreements involve fixing the USD-EUR exchange rate for delivery of a specified amount of foreign currency on a specified date. The currency forward agreements are typically cash settled in U.S. Dollars for their fair value at or close to their settlement date. Cross-currency swaps involve the receipt of functional-currency-fixed-rate amounts from a counterparty in exchange for the Company making foreign-currency- fixed-rate payments over the life of the agreement.

For derivatives designated as net investment hedges, the gain or loss on the derivative is reported in accumulated other comprehensive loss as part of the cumulative translation adjustment. Amounts are reclassified out of accumulated other comprehensive loss into earnings when the hedged net investment is either sold or substantially liquidated.

As of December 31, 2022, the Company had the following outstanding foreign currency derivatives that were used to hedge its net investments in foreign operations:

---

| | | | |
|:---|:---|:---|:---|
| **Foreign Currency Derivative** | **Number of Instruments** | **Notional Sold** | **Notional Purchased** |
| Cross-currency swap | 4 | €100,300 | $105804 |

---

***Fair Value Hedges***

The Company is exposed to changes in the fair value of certain of its foreign denominated intercompany loans due to changes in foreign exchange spot rates. The Company uses fixed-to-fixed cross-currency swaps to hedge its exposure to changes in foreign exchange rates affecting gains and losses on intercompany loan principal and interest. Cross-currency swaps involve the receipt of functional-currency-fixed-rate amounts from a counterparty in exchange for the Company making foreign-currency-fixed-rate payments over the life of the agreement.

------

**<u>[Table of](#i7551ba622ce34f48a2da5a764b6c3dec_7)[Contents](#i7551ba622ce34f48a2da5a764b6c3dec_7)</u>**

For derivatives designated and that qualify as fair value hedges, the gain or loss on the derivative as well as the offsetting loss or gain on the hedged item attributable to the hedged risk are recognized in interest and other financing expense, net.

Gains and losses on the derivative representing hedge components excluded from the assessment of effectiveness are recognized over the life of the hedge on a systematic and rational basis, as documented at hedge inception in accordance with the Company's accounting policy election. The earnings recognition of excluded components is presented in the same income statement line item as the earnings effect of the hedged transaction. During the remaining six months of fiscal 2023, the Company estimates that an additional $239 relating to cross currency swaps will be reclassified as a decrease to interest expense.

As of December 31, 2022, the Company had the following outstanding foreign currency derivatives that were used to hedge changes in fair value attributable to foreign exchange risk:

---

| | | | |
|:---|:---|:---|:---|
| **Foreign Currency Derivative** | **Number of Instruments** | **Notional Sold** | **Notional Purchased** |
| Cross-currency swap | 1 | €24,700 | $26021 |

---

As of December 31, 2022 and June 30, 2022, the following amounts were recorded on the balance sheet related to cumulative basis adjustment for fair value hedges:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Carrying Amount of the Hedged Asset** | **Carrying Amount of the Hedged Asset** | **Cumulative Amount of Fair Value Hedge Adjustment Included in the Carrying Amount of the Hedged Asset** | **Cumulative Amount of Fair Value Hedge Adjustment Included in the Carrying Amount of the Hedged Asset** |
| | **December 31,<br>2022** | **June 30,<br>2022** | **December 31,<br>2022** | **June 30,<br>2022** |
| Intercompany loan receivable | $26441 | $25899 | $2230 | $122 |

---

***Designated Hedges***

The following table presents the fair value of the Company's derivative financial instruments as well as their classification on the Consolidated Balance Sheet as of December 31, 2022:

---

| | | |
|:---|:---|:---|
| | **Asset Derivatives** | **Asset Derivatives** |
| | **Balance Sheet Location** | **Fair Value** |
| <u>Derivatives designated as hedging instruments:</u> |  |  |
| Interest rate swaps | Prepaid expenses and other current assets | $7240 |
| Interest rate swaps | Other noncurrent assets | 5250 |
| Cross-currency swaps | Prepaid expenses and other current assets | 2365 |
| Cross-currency swaps | Other noncurrent assets | 246 |
| Total derivatives designated as hedging instruments |  | $15101 |

---

The following table presents the fair value of the Company's derivative financial instruments as well as their classification on the Consolidated Balance Sheet as of June 30, 2022:

------

**<u>[Table of](#i7551ba622ce34f48a2da5a764b6c3dec_7)[Contents](#i7551ba622ce34f48a2da5a764b6c3dec_7)</u>**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Asset Derivatives** | **Asset Derivatives** | **Liability Derivatives** | **Liability Derivatives** |
| | **Balance Sheet Location** | **Fair Value** | **Balance Sheet Location** | **Fair Value** |
| <u>Derivatives designated as hedging instruments:</u> |  |  |  |  |
| Interest rate swaps | Prepaid expenses and other current assets | $4230 | Accrued expenses and other current liabilities | $— |
| Interest rate swaps | Other noncurrent assets |  | Other noncurrent liabilities | 3184 |
| Cross-currency swaps | Prepaid expenses and other current assets | 2400 | Accrued expenses and other current liabilities |  |
| Cross-currency swaps | Other noncurrent assets | 846 | Other noncurrent liabilities |  |
| Total derivatives designated as hedging instruments |  | $7476 |  | $3184 |

---

The following table presents the pre-tax effect of cash flow hedge accounting on AOCL and Consolidated Statements of Operations for the three months ended December 31, 2022 and 2021:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Derivatives in Cash Flow Hedging Relationships** | **Amount of Gain (Loss) Recognized in AOCL on Derivatives** | **Amount of Gain (Loss) Recognized in AOCL on Derivatives** | **Location of Gain (Loss) Reclassified from AOCL into Income (Expense)** | **Amount of Gain (Loss) Reclassified from AOCL into Income (Expense)** | **Amount of Gain (Loss) Reclassified from AOCL into Income (Expense)** |
| | **Three Months Ended December 31,** | **Three Months Ended December 31,** | | **Three Months Ended December 31,** | **Three Months Ended December 31,** |
|  | **2022** | **2021** |  | **2022** | **2021** |
| Interest rate swaps | $(682) | $772 | Interest and other financing expense, net | $1988 | $(105) |
| Cross-currency swaps |  | 593 | Interest and other financing expense, net / Other expense (income), net | (115) | 664 |
| Foreign currency forward contracts | 80 | (98) | Cost of sales |  | 26 |
| Total | $(602) | $1267 |  | $1873 | $585 |

---

The following table presents the pre-tax effect of cash flow hedge accounting on AOCL and Consolidated Statements of Operations for the six months ended December 31, 2022 and 2021:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Derivatives in Cash Flow Hedging Relationships** | **Amount of Gain (Loss) Recognized in AOCL on Derivatives** | **Amount of Gain (Loss) Recognized in AOCL on Derivatives** | **Location of Gain (Loss) Reclassified from AOCL into Income (Expense)** | **Amount of Gain (Loss) Reclassified from AOCL into Income (Expense)** | **Amount of Gain (Loss) Reclassified from AOCL into Income (Expense)** |
| | **Six Months Ended December 31,** | **Six Months Ended December 31,** | | **Six Months Ended December 31,** | **Six Months Ended December 31,** |
|  | **2022** | **2021** |  | **2022** | **2021** |
| Interest rate swaps | $14580 | $655 | Interest and other financing expense, net | $3135 | $(209) |
| Cross-currency swaps |  | 1369 | Interest and other financing expense, net / Other expense (income), net | (230) | 1402 |
| Foreign currency forward contracts | 80 | (79) | Cost of sales |  | 26 |
| Total | $14660 | $1945 |  | $2905 | $1219 |

---

------

**<u>[Table of](#i7551ba622ce34f48a2da5a764b6c3dec_7)[Contents](#i7551ba622ce34f48a2da5a764b6c3dec_7)</u>**

The following table presents the pre-tax effect of the Company's derivative financial instruments electing cash flow hedge accounting on the Consolidated Statements of Operations for the three months ended of December 31, 2022 and 2021:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Location and Amount of Gain (Loss) Recognized in the Consolidated Statement of Operations on Cash Flow Hedging Relationships** | **Location and Amount of Gain (Loss) Recognized in the Consolidated Statement of Operations on Cash Flow Hedging Relationships** | **Location and Amount of Gain (Loss) Recognized in the Consolidated Statement of Operations on Cash Flow Hedging Relationships** | **Location and Amount of Gain (Loss) Recognized in the Consolidated Statement of Operations on Cash Flow Hedging Relationships** | **Location and Amount of Gain (Loss) Recognized in the Consolidated Statement of Operations on Cash Flow Hedging Relationships** | **Location and Amount of Gain (Loss) Recognized in the Consolidated Statement of Operations on Cash Flow Hedging Relationships** |
| | **Three Months Ended December 31, 2022** | **Three Months Ended December 31, 2022** | **Three Months Ended December 31, 2022** | **Three Months Ended December 31, 2021** | **Three Months Ended December 31, 2021** | **Three Months Ended December 31, 2021** |
| | **Cost of sales** | **Interest and other financing expense, net** | **Other expense/income, net** | **Cost of sales** | **Interest and other financing expense, net** | **Other expense/income, net** |
| <u>The effects of cash flow hedging:</u> |  |  |  |  |  |  |
| Gain (loss) on cash flow hedging relationships |  |  |  |  |  |  |
| Interest rate swaps |  |  |  |  |  |  |
| Amount of gain (loss) reclassified from AOCL into income | $— | $1988 | $— | $— | $(105) | $— |
| Cross-currency swaps |  |  |  |  |  |  |
| Amount of (loss) gain reclassified from AOCL into income | $— | $(115) | $— | $— | $44 | $620 |
| Foreign currency forward contracts |  |  |  |  |  |  |
| Amount of gain reclassified from AOCL into income | $— | $— | $— | $26 | $— | $— |

---

The following table presents the pre-tax effect of the Company's derivative financial instruments electing cash flow hedge accounting on the Consolidated Statements of Operations for the six months ended of December 31, 2022 and 2021:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Location and Amount of Gain (Loss) Recognized in the Consolidated Statement of Operations on Cash Flow Hedging Relationships** | **Location and Amount of Gain (Loss) Recognized in the Consolidated Statement of Operations on Cash Flow Hedging Relationships** | **Location and Amount of Gain (Loss) Recognized in the Consolidated Statement of Operations on Cash Flow Hedging Relationships** | **Location and Amount of Gain (Loss) Recognized in the Consolidated Statement of Operations on Cash Flow Hedging Relationships** | **Location and Amount of Gain (Loss) Recognized in the Consolidated Statement of Operations on Cash Flow Hedging Relationships** | **Location and Amount of Gain (Loss) Recognized in the Consolidated Statement of Operations on Cash Flow Hedging Relationships** |
| | **Six Months Ended December 31, 2022** | **Six Months Ended December 31, 2022** | **Six Months Ended December 31, 2022** | **Six Months Ended December 31, 2021** | **Six Months Ended December 31, 2021** | **Six Months Ended December 31, 2021** |
| | **Cost of sales** | **Interest and other financing expense, net** | **Other expense (income), net** | **Cost of sales** | **Interest and other financing expense, net** | **Other expense (income), net** |
| <u>The effects of cash flow hedging:</u> |  |  |  |  |  |  |
| Gain (loss) on cash flow hedging relationships |  |  |  |  |  |  |
| Interest rate swaps |  |  |  |  |  |  |
| Amount of gain (loss) reclassified from AOCL into income | $— | $3135 | $— | $— | $(209) | $— |
| Cross-currency swaps |  |  |  |  |  |  |
| Amount of (loss) gain reclassified from AOCL into income | $— | $(230) | $— | $— | $85 | $1317 |
| Foreign currency forward contracts |  |  |  |  |  |  |
| Amount of gain reclassified from AOCL into income | $— | $— | $— | $26 | $— | $— |

---

------

**<u>[Table of](#i7551ba622ce34f48a2da5a764b6c3dec_7)[Contents](#i7551ba622ce34f48a2da5a764b6c3dec_7)</u>**

The following table presents the pre-tax effect of fair value hedge accounting on AOCL and Consolidated Statements of Operations as of the three months ended December 31, 2022 and 2021:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Derivatives in Fair Value Hedging Relationships** | **Amount of Loss Recognized in AOCL on Derivatives** | **Amount of Loss Recognized in AOCL on Derivatives** | **Location of Gain Reclassified from AOCL into Income on Derivatives (Amount Excluded from Effectiveness Testing)** | **Amount of Gain Reclassified from AOCL into Income on Derivatives (Amount Excluded from Effectiveness Testing)** | **Amount of Gain Reclassified from AOCL into Income on Derivatives (Amount Excluded from Effectiveness Testing)** |
| | **Three Months Ended December 31,** | **Three Months Ended December 31,** | | **Three Months Ended December 31,** | **Three Months Ended December 31,** |
|  | **2022** | **2021** |  | **2022** | **2021** |
| Cross-currency swaps | $(1416) |  | Interest and other financing expense, net / Other expense (income), net | $123 |  |

---

The following table presents the pre-tax effect of fair value hedge accounting on AOCL and Consolidated Statements of Operations as of the six months ended December 31, 2022 and 2021:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Derivatives in Fair Value Hedging Relationships** | **Amount of Gain Recognized in AOCL on Derivatives** | **Amount of Gain Recognized in AOCL on Derivatives** | **Location of Gain Reclassified from AOCL into Income on Derivatives (Amount Excluded from Effectiveness Testing)** | **Amount of Gain Reclassified from AOCL into Income on Derivatives (Amount Excluded from Effectiveness Testing)** | **Amount of Gain Reclassified from AOCL into Income on Derivatives (Amount Excluded from Effectiveness Testing)** |
| | **Six Months Ended December 31,** | **Six Months Ended December 31,** | | **Six Months Ended December 31,** | **Six Months Ended December 31,** |
|  | **2022** | **2021** |  | **2022** | **2021** |
| Cross-currency swaps | $122 |  | Interest and other financing expense, net / Other expense (income), net | $246 |  |

---

The following table presents the pre-tax effect of the Company's derivative financial instruments electing fair value hedge accounting on the Consolidated Statements of Operations for the three months ended of December 31, 2022 and 2021:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Location and Amount of Gain (Loss) Recognized in the Consolidated Statement of Operations on Fair Value Hedging Relationships** | **Location and Amount of Gain (Loss) Recognized in the Consolidated Statement of Operations on Fair Value Hedging Relationships** | **Location and Amount of Gain (Loss) Recognized in the Consolidated Statement of Operations on Fair Value Hedging Relationships** | **Location and Amount of Gain (Loss) Recognized in the Consolidated Statement of Operations on Fair Value Hedging Relationships** | **Location and Amount of Gain (Loss) Recognized in the Consolidated Statement of Operations on Fair Value Hedging Relationships** | **Location and Amount of Gain (Loss) Recognized in the Consolidated Statement of Operations on Fair Value Hedging Relationships** |
| | **Three Months Ended December 31, 2022** | **Three Months Ended December 31, 2022** | **Three Months Ended December 31, 2022** | **Three Months Ended December 31, 2021** | **Three Months Ended December 31, 2021** | **Three Months Ended December 31, 2021** |
| | **Cost of sales** | **Interest and other financing expense, net** | **Other expense/income, net** | **Cost of sales** | **Interest and other financing expense, net** | **Other expense/income, net** |
| <u>The effects of fair value hedging:</u> |  |  |  |  |  |  |
| Gain (loss) on fair value hedging relationships |  |  |  |  |  |  |
| Cross-currency swaps |  |  |  |  |  |  |
| Amount of loss reclassified from AOCL into income | $— | $(2107) |  | $— | $— | $— |

---

------

**<u>[Table of](#i7551ba622ce34f48a2da5a764b6c3dec_7)[Contents](#i7551ba622ce34f48a2da5a764b6c3dec_7)</u>**

The following table presents the pre-tax effect of the Company's derivative financial instruments electing fair value hedge accounting on the Consolidated Statements of Operations for the six months ended of December 31, 2022 and 2021:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Location and Amount of Gain (Loss) Recognized in the Consolidated Statement of Operations on Fair Value Hedging Relationships** | **Location and Amount of Gain (Loss) Recognized in the Consolidated Statement of Operations on Fair Value Hedging Relationships** | **Location and Amount of Gain (Loss) Recognized in the Consolidated Statement of Operations on Fair Value Hedging Relationships** | **Location and Amount of Gain (Loss) Recognized in the Consolidated Statement of Operations on Fair Value Hedging Relationships** | **Location and Amount of Gain (Loss) Recognized in the Consolidated Statement of Operations on Fair Value Hedging Relationships** | **Location and Amount of Gain (Loss) Recognized in the Consolidated Statement of Operations on Fair Value Hedging Relationships** |
| | **Six Months Ended December 31, 2022** | **Six Months Ended December 31, 2022** | **Six Months Ended December 31, 2022** | **Six Months Ended December 31, 2021** | **Six Months Ended December 31, 2021** | **Six Months Ended December 31, 2021** |
| | **Cost of sales** | **Interest and other financing expense, net** | **Other expense (income), net** | **Cost of sales** | **Interest and other financing expense, net** | **Other expense (income), net** |
| <u>The effects of fair value hedging:</u> |  |  |  |  |  |  |
| Gain (loss) on fair value hedging relationships |  |  |  |  |  |  |
| Cross-currency swaps |  |  |  |  |  |  |
| Amount of loss reclassified from AOCL into income | $— | $(296) | $— | $— | $— | $— |

---

The following table presents the pre-tax effect of the Company's net investment hedges on AOCL and the Consolidated Statements of Operations for the three months ended December 31, 2022 and 2021:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Derivatives in Net Investment Hedging Relationships** | **Amount of (Loss) Gain Recognized in AOCL on Derivatives** | **Amount of (Loss) Gain Recognized in AOCL on Derivatives** | **Location of (Loss) Gain Recognized in (Expense) Income on Derivatives** | **Amount of Gain (Loss) Recognized in Income (Expense) on Derivatives** | **Amount of Gain (Loss) Recognized in Income (Expense) on Derivatives** |
| | **Three Months Ended December 31,** | **Three Months Ended December 31,** | | **Three Months Ended December 31,** | **Three Months Ended December 31,** |
|  | **2022** | **2021** |  | **2022** | **2021** |
| Cross-currency swaps | $(5790) | $1849 | Interest and other financing expense, net | $495 | $140 |

---

The following table presents the pre-tax effect of the Company's net investment hedges on AOCL and the Consolidated Statements of Operations for the six months ended December 31, 2022 and 2021:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Derivatives in Net Investment Hedging Relationships** | **Amount of Gain Recognized in AOCL on Derivatives** | **Amount of Gain Recognized in AOCL on Derivatives** | **Location of (Loss) Gain Recognized in (Expense) Income on Derivatives** | **Amount of (Loss) Gain Recognized in (Expense) Income on Derivatives** | **Amount of (Loss) Gain Recognized in (Expense) Income on Derivatives** |
| | **Six Months Ended December 31,** | **Six Months Ended December 31,** | | **Six Months Ended December 31,** | **Six Months Ended December 31,** |
|  | **2022** | **2021** |  | **2022** | **2021** |
| Cross-currency swaps | $479 | $4267 | Interest and other financing expense, net | $990 | $270 |

---

**Credit-Risk-Related Contingent Features**

The Company has agreements with each of its derivative counterparties that contain a provision providing that upon certain defaults by the Company on any of its indebtedness, the Company could also be declared in default on its derivative obligations.

**16.&nbsp;&nbsp;&nbsp;&nbsp;COMMITMENTS AND CONTINGENCIES**

*Securities Class Actions Filed in Federal Court*

On August 17, 2016, three securities class action complaints were filed in the Eastern District of New York (the "District Court") against the Company alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. The three complaints are: (1) *Flora v. The Hain Celestial Group, Inc., et al.* (the "Flora Complaint"); (2) *Lynn v. The Hain Celestial Group, Inc., et al.* (the "Lynn Complaint"); and (3) *Spadola v. The Hain Celestial Group, Inc., et al.* (the "Spadola Complaint" and, together with the Flora and Lynn Complaints, the "Securities Complaints"). On June 5, 2017, the District Court issued an order for consolidation, appointment of Co-Lead Plaintiffs and approval of selection of co-lead counsel.

------

**<u>[Table of](#i7551ba622ce34f48a2da5a764b6c3dec_7)[Contents](#i7551ba622ce34f48a2da5a764b6c3dec_7)</u>**

Pursuant to this order, the Securities Complaints were consolidated under the caption In re The Hain Celestial Group, Inc. Securities Litigation (the "Consolidated Securities Action"), and Rosewood Funeral Home and Salamon Gimpel were appointed as Co-Lead Plaintiffs. On June 21, 2017, the Company received notice that plaintiff Spadola voluntarily dismissed his claims without prejudice to his ability to participate in the Consolidated Securities Action as an absent class member. The Co-Lead Plaintiffs in the Consolidated Securities Action filed a Consolidated Amended Complaint on August 4, 2017 and a Corrected Consolidated Amended Complaint on September 7, 2017 on behalf of a purported class consisting of all persons who purchased or otherwise acquired Hain Celestial securities between November 5, 2013 and February 10, 2017 (the "Amended Complaint"). The Amended Complaint named as defendants the Company and certain of its former officers (collectively, "Defendants") and asserted violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 based on allegedly materially false or misleading statements and omissions in public statements, press releases and SEC filings regarding the Company's business, prospects, financial results and internal controls. Defendants filed a motion to dismiss the Amended Complaint on October 3, 2017 which the District Court granted on March 29, 2019, dismissing the case in its entirety, without prejudice to replead. Co-Lead Plaintiffs filed a Second Amended Consolidated Class Action Complaint on May 6, 2019 (the "Second Amended Complaint"). The Second Amended Complaint again named as defendants the Company and certain of its former officers and asserts violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 based on allegations similar to those in the Amended Complaint, including materially false or misleading statements and omissions in public statements, press releases and SEC filings regarding the Company's business, prospects, financial results, and internal controls. Defendants filed a motion to dismiss the Second Amended Complaint on June 20, 2019. On April 6, 2020, the District Court granted Defendants' motion to dismiss the Second Amended Complaint in its entirety, with prejudice. Co-Lead Plaintiffs appealed the District Court's decision dismissing the Second Amended Complaint to the United States Court of Appeals for the Second Circuit (the "Second Circuit"). By decision dated December 17, 2021, the Second Circuit vacated the District Court's judgment and remanded the case for further proceedings. On April 6, 2022, the District Court issued an order directing the parties to submit position papers outlining their views regarding: (a) the scope of the Court's reconsideration of Defendants' Motion to Dismiss the Second Amended Complaint; and (b) the appropriate procedure the Court should follow in light of the Second Circuit's opinion. On April 14, 2022, the District Court entered an order setting the schedule for, and determining the scope of, supplemental briefing on Defendants' Motion to Dismiss the Second Amended Complaint. The parties submitted supplemental briefing between May 12, 2022 and June 23, 2022. In June 2022, the District Court referred Defendants' Motion to Dismiss the Second Amended Complaint to a United States Magistrate Judge (the "Magistrate Judge") for a Report and Recommendation. On November 4, 2022, the Magistrate Judge issued a Report and Recommendation recommending that the District Court grant Defendants' Motion to Dismiss the Second Amended Complaint with prejudice. Plaintiffs filed Objections to Magistrate Judge's November 4, 2022 Report and Recommendation on December 7, 2022, and Defendants filed their Opposition to Plaintiffs' Objections to Magistrate Judge's November 4, 2022 Report and Recommendation on January 9, 2023. The Parties await a decision from the District Court on Defendants' Motion to Dismiss the Second Amended Complaint.

*Additional Stockholder Class Action and Derivative Complaints Filed in Federal Court*

On April 19, 2017 and April 26, 2017, two class action and stockholder derivative complaints were filed in the Eastern District of New York against the former Board of Directors and certain former officers of the Company under the captions Silva v. Simon, et al. (the "Silva Complaint") and Barnes v. Simon, et al. (the "Barnes Complaint"), respectively. Both the Silva Complaint and the Barnes Complaint allege violation of securities law, breach of fiduciary duty, waste of corporate assets and unjust enrichment.

On May 23, 2017, an additional stockholder filed a complaint under seal in the Eastern District of New York against the former Board of Directors and certain former officers of the Company. The complaint alleged that the Company's former directors and certain former officers made materially false and misleading statements in press releases and SEC filings regarding the Company's business, prospects and financial results. The complaint also alleged that the Company violated its by-laws and Delaware law by failing to hold its 2016 Annual Stockholders Meeting and includes claims for breach of fiduciary duty, unjust enrichment and corporate waste. On August 9, 2017, the District Court granted an order to unseal this case and reveal Gary Merenstein as the plaintiff (the "Merenstein Complaint").

On August 10, 2017, the District Court granted the parties' stipulation to consolidate the Barnes Complaint, the Silva Complaint and the Merenstein Complaint under the caption In re The Hain Celestial Group, Inc. Stockholder Class and Derivative Litigation (the "Consolidated Stockholder Class and Derivative Action") and to appoint Robbins Arroyo LLP and Scott+Scott as Co-Lead Counsel, with the Law Offices of Thomas G. Amon as Liaison Counsel for Plaintiffs. On September 14, 2017, a related complaint was filed under the caption Oliver v. Berke, et al. (the "Oliver Complaint"), and on October 6, 2017, the Oliver Complaint was consolidated with the Consolidated Stockholder Class and Derivative Action. The Plaintiffs filed their consolidated amended complaint under seal on October 26, 2017. On December 20, 2017, the parties agreed to stay Defendants' time to answer, move, or otherwise respond to the consolidated amended complaint through and including 30 days

------

**<u>[Table of](#i7551ba622ce34f48a2da5a764b6c3dec_7)[Contents](#i7551ba622ce34f48a2da5a764b6c3dec_7)</u>**

after a decision was rendered on the motion to dismiss the Amended Complaint in the Consolidated Securities Action, described above.

On March 29, 2019, the District Court in the Consolidated Securities Action granted Defendants' motion, dismissing the Amended Complaint in its entirety, without prejudice to replead. Co-Lead Plaintiffs in the Consolidated Securities Action filed the Second Amended Complaint on May 6, 2019. The parties to the Consolidated Stockholder Class and Derivative Action agreed to continue the stay of Defendants' time to answer, move, or otherwise respond to the consolidated amended complaint through 30 days after a decision on Defendants' motion to dismiss the Second Amended Complaint in the Consolidated Securities Action.

On April 6, 2020, the District Court granted Defendants' motion to dismiss the Second Amended Complaint in the Consolidated Securities Action, with prejudice. Pursuant to the terms of the stay, Defendants in the Consolidated Stockholder Class and Derivative Action had until May 6, 2020 to answer, move, or otherwise respond to the complaint in this matter. This deadline was extended, and Defendants moved to dismiss the Consolidated Stockholder Class and Derivative Action Complaint on June 23, 2020, with Plaintiffs' opposition due August 7, 2020.

On July 24, 2020, Plaintiffs made a stockholder litigation demand on the current Board containing overlapping factual allegations to those set forth in the Consolidated Stockholder Class and Derivative Action. On August 10, 2020, the District Court vacated the briefing schedule on Defendants' pending motion to dismiss in order to give the Board of Directors time to consider the demand. On each of September 8 and October 8, 2020, the District Court extended its stay of any applicable deadlines for 30 days to give the Board of Directors additional time to complete its evaluation of the demand. On November 3, 2020, Plaintiffs were informed that the Board of Directors had finished investigating and resolved, among other things, that the demand should be rejected. On November 6, 2020, Plaintiffs and Defendants notified the District Court that Plaintiffs were evaluating the rejection of the demand, sought certain additional information and were assessing next steps, and requested that the District Court extend the stay for an additional 30 days, to on or around December 7, 2020. The Parties then filed a number of additional joint status reports, requesting that the District Court continue the stay of applicable deadlines through December 30, 2021. In light of the Second Circuit vacating the District Court's judgment in the Consolidated Securities Action referenced above and remanding the case for further proceedings, the Parties submitted a joint status report on December 29, 2021 requesting that the District Court continue the temporary stay pending the District Court's reconsideration of the Defendants' motion to dismiss the Second Amended Complaint in the Consolidated Securities Action. The District Court has extended the temporary stay through April 30, 2023.

*Baby Food Litigation*

Since February 2021, the Company has been named in numerous consumer class actions alleging that the Company's Earth's Best<sup>®</sup> baby food products (the "Products") contain unsafe and undisclosed levels of various naturally occurring heavy metals, namely lead, arsenic, cadmium and mercury. Those actions have now been transferred and consolidated as a single lawsuit in the U.S. District Court for the Eastern District of New York captioned In re Hain Celestial Heavy Metals Baby Food Litigation, Case No. 2:21-cv-678 (the "Consolidated Proceeding"), which generally alleges that the Company violated various state consumer protection laws and asserts other state and common law warranty and unjust enrichment claims related to the alleged failure to disclose the presence of these metals, arguing that consumers would have either not purchased the Products or would have paid less for them had the Company made adequate disclosures. The Court appointed interim class counsel for Plaintiffs in the Consolidated Proceeding, and Plaintiffs filed a Consolidated Amended Class Action Complaint on March 18, 2022. The Company filed a motion to dismiss the Consolidated Class Action Complaint on November 7, 2022. The plaintiffs filed their opposition on December 22, 2022, and the Company filed its reply brief on January 20, 2023. One consumer class action is pending in New York Supreme Court, Nassau County, which the court has stayed in deference to the Consolidated Proceeding. The Company denies the allegations in these lawsuits and contends that its baby foods are safe and properly labeled.

The claims raised in these lawsuits were brought in the wake of a highly publicized report issued by the U.S. House of Representatives Subcommittee on Economic and Consumer Policy on Oversight and Reform, dated February 4, 2021 (the "House Report"), addressing the presence of heavy metals in baby foods made by certain manufacturers, including the Company. Since the publishing of the House Report, the Company has also received information requests with respect to the advertising and quality of its baby foods from certain governmental authorities, as such authorities investigate the claims made in the House Report. The Company is fully cooperating with these requests and is providing documents and other requested information. The Company has been named in one civil government enforcement action, State of New Mexico ex rel. Balderas v. Nurture, Inc., et al., which was filed by the New Mexico Attorney General against the Company and several other manufacturers based on the alleged presence of heavy metals in their baby food products. The Company and several other manufacturers moved to dismiss the New Mexico Attorney General's lawsuit, which motion the Court denied. The Company filed its answer to the New Mexico Attorney General's amended complaint on April 23, 2022. The Company denies the New

------

**<u>[Table of](#i7551ba622ce34f48a2da5a764b6c3dec_7)[Contents](#i7551ba622ce34f48a2da5a764b6c3dec_7)</u>**

Mexico Attorney General's allegations and maintains that its baby foods are safe, properly labeled, and compliant with New Mexico law.

In addition to the consumer class actions discussed above, the Company is currently named in six lawsuits in state and federal courts alleging some form of personal injury from the ingestion of the Company's Products, purportedly due to unsafe and undisclosed levels of various naturally occurring heavy metals. These lawsuits generally allege injuries related to neurological development disorders such as autism and attention deficit hyperactivity disorder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• In the matter, *Palmquist et al. v. The Hain Celestial Group, Inc.*, pending in U.S. District Court, Southern District of Texas, the trial proceedings commenced on February 6, 2023.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• In the matter, *NC v. The Hain Celestial Group, et al.*, pending in Superior Court for the State of California, County of Los Angeles, the Court has set a trial date of October 4, 2023. The parties are currently engaging in discovery. Fact discovery is set to close on March 24, 2023, and expert discovery is set to close on May 5, 2023.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• There are currently two Nevada state court cases pending in Clark County District Court. The cases, *Benitez v. Beech-Nut Nutrition Company, Inc., et al.* and *Buenaventura v. Beech-Nut Nutrition Company, Inc., et al.*, have been consolidated for the purposes of discovery only. In *Benitez*, the Court issued a scheduling order in September 2022. Pursuant to this Order, discovery will close on March 7, 2024 and the case is set the case for trial starting on July 29, 2024. There has been no further activity in the *Buenaventura* case.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• In *Watkins v. Plum, PBC, et al.*, currently pending in the United States District Court for the Eastern District of Louisiana, the Court has set the case for trial beginning on August 28, 2023. The parties have started to engage in discovery.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• On January 9, 2023, Plaintiffs in *P.A. et al. v. Hain Celestial Group, Inc.* filed their First Amended Complaint in the Circuit Court of the First Circuit, State of Hawai'i. Defendants have not yet responded to this Complaint.

The Company denies that its Products led to any of the alleged injuries and will defend these cases vigorously. That said, additional lawsuits may be filed against the Company in the future, asserting similar or different legal theories and seeking similar or different types of damages and relief. Such lawsuits may be resolved in a manner adverse to us, and we may incur substantial costs or damages not covered by our insurance, which could have a material adverse effect on our financial condition and business.

*Other*

In addition to the litigation described above, the Company is and may be a defendant in lawsuits from time to time in the normal course of business.

With respect to all litigation and related matters, the Company records a liability when the Company believes it is probable that a liability has been incurred and the amount can be reasonably estimated. As of the end of the period covered by this report, the Company has not recorded a liability for any of the matters disclosed in this note. It is possible that some matters could require the Company to pay damages, incur other costs or establish accruals in amounts that could not be reasonably estimated as of the end of the period covered by this report.

**17.&nbsp;&nbsp;&nbsp;&nbsp;SEGMENT INFORMATION**

Our organization structure consists of two geographic-based reportable segments: North America and International. Our North America reportable segment consists of the United States and Canada as operating segments. Our International reportable segment is comprised of three operating segments: United Kingdom, Ella's Kitchen UK, and Europe. This structure is in line with how our Chief Operating Decision Maker ("CODM"), the Company's Chief Executive Officer, assesses our performance and allocates resources.

We use segment net sales and operating income to evaluate performance and to allocate resources. We believe these measures are most relevant in order to analyze segment results and trends. Segment operating income excludes certain general corporate expenses (which are a component of selling, general and administrative expenses), impairment and acquisition related expenses, restructuring, integration, and other charges.

------

**<u>[Table of](#i7551ba622ce34f48a2da5a764b6c3dec_7)[Contents](#i7551ba622ce34f48a2da5a764b6c3dec_7)</u>**

The following tables set forth financial information about each of the Company's reportable segments. Transactions between reportable segments were insignificant for all periods presented.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended December 31,** | **Three Months Ended December 31,** | **Six Months Ended December 31,** | **Six Months Ended December 31,** |
| | **2022** | **2021** | **2022** | **2021** |
| <u>Net Sales:</u> |  |  |  |  |
| North America | $282361 | $275014 | $570757 | $540539 |
| International | 171847 | 201927 | 322802 | 391305 |
|  | $454208 | $476941 | $893559 | $931844 |
| <u>Operating Income (Loss):</u> |  |  |  |  |
| North America | $32262 | $27162 | $56707 | $44004 |
| International | 11940 | 27368 | 19615 | 51437 |
|  | 44202 | 54530 | 76322 | 95441 |
| Corporate and Other <sup>(a)</sup> | (16813) | (22509) | (33110) | (37873) |
|  | $27389 | $32021 | $43212 | $57568 |

---

<sup>(a)</sup> *In addition to general Corporate and Other expenses as described above, for the three and six months ended December 31, 2022, Corporate and Other included $436 and $530 of Productivity and transformation costs, respectively. For the three and six months ended December 31, 2021, Corporate and Other included $953 and $3,010 of Productivity and transformation costs, respectively.*

The Company's net sales by geographic region, which are generally based on the location of the Company's subsidiaries, were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended December 31,** | **Three Months Ended December 31,** | **Six Months Ended December 31,** | **Six Months Ended December 31,** |
| | **2022** | **2021** | **2022** | **2021** |
| United States | $255056 | $243909 | $514563 | $477396 |
| United Kingdom | 123578 | 139352 | 232738 | 263100 |
| All Other | 75574 | 93680 | 146258 | 191348 |
| Total | $454208 | $476941 | $893559 | $931844 |

---

The Company's long-lived assets, which represent net property, plant and equipment and operating lease right-of-use assets, were as follows by geographic area:

---

| | | |
|:---|:---|:---|
| | **December 31,<br>2022** | **June 30,<br>2022** |
| United States | $170184 | $182038 |
| United Kingdom | 132116 | 133213 |
| All Other | 93709 | 96845 |
| Total | $396009 | $412096 |

---

------

**<u>[Table of](#i7551ba622ce34f48a2da5a764b6c3dec_7)[Contents](#i7551ba622ce34f48a2da5a764b6c3dec_7)</u>**

**Item 2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Management's Discussion and Analysis of Financial Condition and Results of Operations**

*This Management's Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with the Consolidated Financial Statements and the related Notes thereto for the period ended December 31, 2022 contained in this Quarterly Report on Form 10-Q and our Annual Report on Form 10-K for the fiscal year ended June 30, 2022. Forward- looking statements in this Form 10-Q are qualified by the cautionary statement included in this Form 10-Q under the sub-heading "Forward-Looking Statements" in the introduction of this Form 10-Q.* 

***Overview***

The Hain Celestial Group, Inc., a Delaware corporation (collectively, along with its subsidiaries, the "Company," and herein referred to as "Hain Celestial," "we," "us" and "our"), was founded in 1993 and is headquartered in Lake Success, New York. The Company's mission has continued to evolve since its founding, with health and wellness being the core tenet. The Company continues to be a leading marketer, manufacturer and seller of organic and natural, "better-for-you" products by anticipating and exceeding consumer expectations in providing quality, innovation, value and convenience. The Company is committed to growing sustainably while continuing to implement environmentally sound business practices and manufacturing processes. Hain Celestial sells its products through specialty and natural food distributors, supermarkets, natural food stores, mass-market and e-commerce retailers, food service channels and club, drug and convenience stores in over 75 countries worldwide.

The Company manufactures, markets, distributes, and sells organic and natural products, providing consumers with the opportunity to lead A Healthier Way of Life<sup>®</sup>. The Company's food and beverage brands include Celestial Seasonings<sup>®</sup>, Clarks™, Cully & Sully<sup>®</sup>, Earth's Best<sup>®</sup>, Ella's Kitchen<sup>®</sup>, Frank Cooper's<sup>®</sup>, Garden of Eatin'<sup>®</sup>, Hartley's<sup>®</sup>, Health Valley<sup>®</sup>, Imagine<sup>®</sup>, Joya<sup>®</sup>, Lima<sup>®</sup>, Linda McCartney's<sup>®</sup> (under license), MaraNatha<sup>®</sup>, Natumi<sup>®</sup>, New Covent Garden Soup Co.<sup>®</sup>, ParmCrisps<sup>®</sup>, Robertson's<sup>®</sup>, Rose's<sup>®</sup> (under license), Sensible Portions<sup>®</sup>, Spectrum<sup>®</sup>, Sun-Pat<sup>®</sup>, Terra<sup>®</sup>, The Greek Gods<sup>®</sup>, Thinsters<sup>®</sup>, Yorkshire Provender<sup>®</sup> and Yves Veggie Cuisine<sup>®</sup>. The Company's personal care brands include Alba Botanica<sup>®</sup>, Avalon Organics<sup>®</sup>, JASON<sup>®</sup>, Live Clean<sup>®</sup> and Queen Helene<sup>®</sup>.

***Global Economic Environment***

Economic conditions during fiscal year 2022 and the first half of fiscal year 2023 have been marked by inflationary pressures, rising interest rates and shifts in consumer demand.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Inflation* – The inflationary environment has led to higher costs for ingredients, packaging, energy, transportation and other supply chain components. We expect this higher cost environment to continue, although we expect these higher costs to be partially mitigated by pricing actions we have implemented to date and further pricing actions that we may implement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Interest Rates* – Loans under our credit agreement bear interest at a variable rate, and the interest rate on our outstanding indebtedness has increased as market interest rates have risen significantly starting in the second half of fiscal year 2022. These higher interest rates, together with a higher outstanding debt balance, has led to an increase in our interest expense, which we expect to continue.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Consumer Demand* – Recent economic conditions have resulted in changes in consumer spending patterns, which has had an impact on our sales. During an economic downturn, factors such as increased unemployment, decreases in disposable income and declines in consumer confidence can cause changes in consumer spending behavior, particularly with respect to higher priced better-for-you products. Economic conditions have prompted some consumers, particularly in Europe, to shift to lower-priced products.

***Supply Chain Disruptions***

We continue to experience disruption in our supply chain network, including the supply of certain ingredients, packaging, and other sourced materials. These disruptions, in addition to the higher costs described above, have resulted in higher inventory levels. In some cases the disruptions result in an inability to fulfill certain customer orders, which can lead to fines from the customers. Although we believe the unprecedented industry-wide supply chain disruptions are largely behind us, it is possible that additional disruptions to our supply chain could occur.

------

**<u>[Table of](#i7551ba622ce34f48a2da5a764b6c3dec_7)[Contents](#i7551ba622ce34f48a2da5a764b6c3dec_7)</u>**

***Russia-Ukraine War***

Although we have no material assets in Russia, Belarus or Ukraine, our supply chain was adversely impacted by the Russia-Ukraine war during the second half of fiscal year 2022 and the first half of fiscal year 2023 and we continue to face other challenges and risks arising from the war. In particular, the war has added significant costs to existing inflationary pressures through increased energy and raw material prices. Further, beyond increased costs, labor challenges and other factors have led to supply chain disruptions. While, to date, we have been able to identify replacement raw materials where necessary, we have incurred increased costs in doing so. The war has also negatively impacted consumer sentiment, particularly in Europe, with some consumers shifting to lower-priced products, which has somewhat affected demand for our products. Additionally, we face increased cybersecurity risks, as companies based in the United States and its allied countries have become targets of malicious cyber activity. While we are continuing to monitor and manage the impacts of the war on our business, the extent to which the Russia-Ukraine war and the related economic impact may affect our financial condition or results of operations in the future remains uncertain.

***COVID-19***

The COVID-19 pandemic continues to contribute to the challenging economic conditions described above, including manufacturing and supply chain challenges, labor market shortages and changing consumer behaviors amid uncertain economic conditions.

***Acquisition***

On December 28, 2021, the Company acquired all outstanding stock of Proven Brands, Inc. (and its subsidiary That's How We Roll LLC) and KTB Foods Inc., collectively doing business as "That's How We Roll" ("THWR"), the producer and marketer of ParmCrisps<sup>®</sup> and Thinsters<sup>®</sup>. See Note 4, *Acquisitions and Dispositions*, in the Notes to the Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q.

***Disposition***

On December 15, 2022, the Company completed the divestiture of its Westbrae Natural<sup>®</sup> brand ("Westbrae") for total cash consideration of $7,498. The sale of Westbrae is consistent with the Company's portfolio simplification process, to focus on the brands and categories with the most growth potential. Westbrae operated out of the United States and was part of the Company's North America reportable segment.

***CEO Succession***

On November 22, 2022, the Board of Directors (the "Board") of the Company approved a succession plan pursuant to which Mark L. Schiller transitioned from his position as President and Chief Executive Officer of the Company effective as of December 31, 2022 (the "Transition Date"). Mr. Schiller remains as a director on the Board following the Transition Date. The Board appointed Wendy P. Davidson to the role of President and Chief Executive Officer and as a director on the Board, in each case effective as of January 1, 2023 (the "Start Date").

------

**<u>[Table of](#i7551ba622ce34f48a2da5a764b6c3dec_7)[Contents](#i7551ba622ce34f48a2da5a764b6c3dec_7)</u>**

**Comparison of Three Months Ended December 31, 2022 to Three Months Ended December 31, 2021** 

***Consolidated Results***

The following table compares our results of operations, including as a percentage of net sales, on a consolidated basis, for the three months ended December 31, 2022 and 2021 (amounts in thousands, other than per share data and percentages, which may not add due to rounding):

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Change in** | **Change in** |
| | **December 31, 2022** | **December 31, 2022** | **December 31, 2021** | **December 31, 2021** | **Dollars** | **Percentage** |
| Net sales | $454208 | 100.0% | $476941 | 100.0% | $(22733) | (4.8)% |
| Cost of sales | 350351 | 77.1% | 359646 | 75.4% | (9295) | (2.6)% |
| Gross profit | 103857 | 22.9% | 117295 | 24.6% | (13438) | (11.5)% |
| Selling, general and administrative expenses | 72357 | 15.9% | 80136 | 16.8% | (7779) | (9.7)% |
| Amortization of acquired intangible assets | 2785 | 0.6% | 2049 | 0.4% | 736 | 35.9% |
| Productivity and transformation costs | 986 | 0.2% | 2786 | 0.6% | (1800) | (64.6)% |
| Long-lived asset impairment | 340 | 0.1% | 303 | 0.1% | 37 | 12.2% |
| Operating income | 27389 | 6.0% | 32021 | 6.7% | (4632) | (14.5)% |
| Interest and other financing expense, net | 10812 | 2.4% | 2592 | 0.5% | 8220 | 317.1% |
| Other income, net | (1062) | (0.2)% | (9070) | (1.9)% | 8008 | (88.3)% |
| Income before income taxes and equity in net loss of equity-method investees | 17639 | 3.9% | 38499 | 8.1% | (20860) | (54.2)% |
| Provision for income taxes | 6357 | 1.4% | 7145 | 1.5% | (788) | (11.0)% |
| Equity in net loss of equity-method investees | 316 | 0.1% | 465 | 0.1% | (149) | (32.0)% |
| Net income | $10966 | 2.4% | $30889 | 6.5% | $(19923) | (64.5)% |
| Adjusted EBITDA | $49817 | 11.0% | $59264 | 12.4% | $(9447) | (15.9)% |
| Diluted net income per common share | $0.12 |  | $0.33 |  | $(0.21) | (63.6)% |

---

<u>Net Sales</u>

Net sales for the three months ended December 31, 2022 were $454.2 million, a decrease of $22.7 million, or 4.8%, as compared to $476.9 million in the three months ended December 31, 2021. On a constant currency basis, adjusted for the impact of acquisitions, divestitures and discontinued brands, net sales decreased approximately $11.5 million, or 2.4%, from the prior year quarter driven by both the North America and International reportable segments. Further details of changes in net sales by segment are provided below in the *Segment Results* section.

<u>Gross Profit</u>

Gross profit for the three months ended December 31, 2022 was $103.9 million, a decrease of $13.4 million, or 11.5%, as compared to the prior year quarter. Additionally, gross profit margin of 22.9% was lower when compared with 24.6% in the prior year quarter. The decrease in gross profit was driven primarily by the International reportable segment mainly resulting from lower net sales in the United Kingdom and Europe operating segments, higher energy and supply chain costs, and under-absorption of overhead costs at our manufacturing facilities when compared to the prior year period. The North America reportable segment had an increase in gross profit mainly driven by pricing increases and cost improvements due to higher productivity, partly offset by inflation and lower net sales in the Canada operating segment when compared with the prior year quarter.

------

**<u>[Table of](#i7551ba622ce34f48a2da5a764b6c3dec_7)[Contents](#i7551ba622ce34f48a2da5a764b6c3dec_7)</u>**

<u>Selling, General and Administrative Expenses</u>

Selling, general and administrative expenses were $72.4 million for the three months ended December 31, 2022, a decrease of $7.8 million, or 9.7%, from $80.1 million for the prior year quarter. The decrease was driven by lower labor-related expenses primarily in Corporate, marketing costs primarily in the North America reportable segment as well as efficiencies gained from the Company's productivity and transformation initiatives.

<u>Amortization of Acquired Intangible Assets</u>

Amortization of acquired intangibles was $2.8 million for the three months ended December 31, 2022, an increase of $0.7 million from $2.0 million in the prior year quarter due to the acquisition of THWR in the second quarter of the prior fiscal year.

<u>Productivity and Transformation Costs</u>

Productivity and transformation costs were $1.0 million for the three months ended December 31, 2022, a decrease of $1.8 million from $2.8 million in the prior year quarter. The decrease was primarily due to reduced spending related to productivity and transformation initiatives as the current transformation effort approaches its conclusion.

<u>Long-lived Asset Impairment</u> 

During the three months ended December 31, 2022 the Company recognized an impairment charge of $0.3 million, relating to a facility in the United States. During the three months ended December 31, 2021, the Company recognized a pre-tax impairment charge of $0.3 million related to a facility in the United Kingdom.

<u>Operating Income</u>

Operating income for the three months ended December 31, 2022 was $27.4 million compared to $32.0 million in the prior year quarter as a result of the items described above.

<u>Interest and Other Financing Expense, Net</u>

Interest and other financing expense, net totaled $10.8 million for the three months ended December 31, 2022, an increase of $8.2 million, or 317.1%, from $2.6 million in the prior year quarter. The increase resulted primarily from rising interest rates and a higher outstanding debt balance driven primarily by the acquisition of THWR in the second quarter of the prior fiscal year as well as share repurchase activity during fiscal 2022. See Note 9, *Debt and Borrowings*, in the Notes to the Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q.

<u>Other Income, Net</u>

Other income, net totaled $1.1 million for the three months ended December 31, 2022, compared to $9.1 million in the prior year quarter. The decrease in income was primarily attributable to the gain on sale of assets related to the sale of undeveloped land plots in Boulder, Colorado resulting in a gain of $8.7 million in the prior year quarter.

<u>Income Before Income Taxes and Equity in Net Loss of Equity-Method Investees</u>

Income before income taxes and equity in net loss of our equity-method investees for the three months ended December 31, 2022 was $17.6 million compared to $38.5 million in the prior year quarter. The decrease was due to the items discussed above.

<u>Provision for Income Taxes</u>

The provision for income taxes includes federal, foreign, state and local income taxes. Our income tax expense was $6.4 million for the three months ended December 31, 2022 compared to an income tax expense of $7.1 million in the prior year quarter.

The effective income tax rate was an expense of 36.0% and 18.6% for the three months ended December 31, 2022 and 2021, respectively. The effective income tax rate for the three months ended December 31, 2022 was impacted by the gain on sale of Westbrae, an operating lease modification during the second quarter, severance with respect to our former CEO (as part of the limitation on the deductibility of executive compensation), stock-based compensation and uncertain tax positions. The effective income tax rate for the three months ended December 31, 2021 was impacted by deductions related to stock-based

------

**<u>[Table of](#i7551ba622ce34f48a2da5a764b6c3dec_7)[Contents](#i7551ba622ce34f48a2da5a764b6c3dec_7)</u>**

compensation, non-deductible transaction costs related to the acquisition of THWR and the reversal of a valuation allowance due to the utilization of a capital loss carryover. The effective income tax rates in each period were also impacted by the geographical mix of earnings and state income taxes.

<u>Equity in Net Loss of Equity-Method Investees</u>

Our equity in net loss from our equity-method investments for the three months ended December 31, 2022 was $0.3 million and $0.5 million in the prior year quarter. See Note 13, *Investments*, in the Notes to the Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q.

<u>Net Income</u>

Net income for the three months ended December 31, 2022 was $11.0 million, or $0.12 per diluted share, compared to $30.9 million, or $0.33 per diluted share, in the prior year quarter. The change was attributable to the factors noted above.

<u>Adjusted EBITDA</u>

Our Adjusted EBITDA was $49.8 million and $59.3 million for the three months ended December 31, 2022 and 2021, respectively, as a result of the factors discussed above, and the adjustments described in the *Reconciliation of Non-U.S. GAAP Financial Measures to U.S. GAAP Measures* presented following the discussion of our results of operations. On a constant currency basis, Adjusted EBITDA decreased by $6.5 million, or 11.0%, from $59.3 million for the three months ended December 31, 2021 to $52.7 million for the three months ended December 31, 2022.

------

**<u>[Table of](#i7551ba622ce34f48a2da5a764b6c3dec_7)[Contents](#i7551ba622ce34f48a2da5a764b6c3dec_7)</u>**

***Segment Results***

The following table provides a summary of net sales and operating income (loss) by reportable segment for the three months ended December 31, 2022 and 2021:

---

| | | | | |
|:---|:---|:---|:---|:---|
| *(dollars in thousands)* | **North America** | **International** | **Corporate and Other** | **Consolidated** |
| <u>Net sales</u> |  |  |  |  |
| Three months ended 12/31/22 | $282361 | $171847 | $— | $454208 |
| Three months ended 12/31/21 | 275014 | 201927 |  | 476941 |
| &nbsp;&nbsp;&nbsp;$ change | $7347 | $(30080) | n/a | $(22733) |
| &nbsp;&nbsp;&nbsp;% change | 2.7% | (14.9)% | n/a | (4.8)% |
| <u>Operating income (loss)</u> |  |  |  |  |
| Three months ended 12/31/22 | $32262 | $11940 | $(16813) | $27389 |
| Three months ended 12/31/21 | 27162 | 27368 | (22509) | 32021 |
| &nbsp;&nbsp;&nbsp;$ change | $5100 | $(15428) | $5696 | $(4632) |
| &nbsp;&nbsp;&nbsp;% change | 18.8% | (56.4)% | (25.3)% | (14.5)% |
| <u>Operating income margin</u> |  |  |  |  |
| Three months ended 12/31/22 | 11.4% | 6.9% | n/a | 6.0% |
| Three months ended 12/31/21 | 9.9% | 13.6% | n/a | 6.7% |

---

<u>North America</u>

Our net sales in the North America reportable segment for the three months ended December 31, 2022 were $282.4 million, an increase of $7.3 million, or 2.7%, from net sales of $275.0 million in the prior year quarter. On a constant currency basis, adjusted for the impact of acquisitions, divestitures and discontinued brands, net sales decreased by 1.9%. In the United States operating segment, adjusted sales were lower compared to the prior year quarter mainly due to retailer inventory adjustments, particularly in tea, and lower sales in personal care, partially offset by higher sales in snacks. Similar trends were noted in the Canada operating segment. Sales were also impacted by the industry-wide formula and pouch supply challenges in the baby food category. Operating income in North America for the three months ended December 31, 2022 was $32.3 million, an increase of $5.1 million from $27.2 million in the prior year quarter. The increase was mainly driven by pricing increases, cost improvements due to higher productivity, and lower marketing spend, partially offset by inflation.

<u>International</u> 

Our net sales in the International reportable segment for the three months ended December 31, 2022 were $171.8 million, a decrease of $30.1 million, or 14.9%, from net sales of $201.9 million in the prior year quarter. On a constant currency basis, net sales decreased 3.2% from the prior year quarter primarily due to a decline in sales in the Europe operating segments, partially offset by an increase in sales in the Ella's Kitchen UK and United Kingdom operating segments. In the Europe operating segment, net sales were lower due to continued softness in plant-based categories and non-dairy beverages, including the impact of the loss of a large non-dairy co-manufacturing customer in the second half of the prior fiscal year. Operating income in our International reportable segment for the three months ended December 31, 2022 was $11.9 million, a decrease of $15.4 million from operating income of $27.4 million for the three months ended December 31, 2021. Operating income was lower in the current quarter when compared to the prior year quarter mainly due to lower gross profit resulting from a decline in sales, higher energy and supply chain costs, and under-absorption of overhead costs at our manufacturing facilities.

------

**<u>[Table of](#i7551ba622ce34f48a2da5a764b6c3dec_7)[Contents](#i7551ba622ce34f48a2da5a764b6c3dec_7)</u>**

<u>Corporate and Other</u>

Our Corporate and Other category consists of expenses related to the Company's centralized administrative functions, which do not specifically relate to an operating segment. Such Corporate and Other expenses are comprised mainly of compensation and related expenses of certain of the Company's senior executive officers and other employees who perform duties related to our entire enterprise as well as expenses for certain professional fees, acquisition and divestiture transaction costs, facilities, and other items which benefit the Company as a whole. Our operating loss in Corporate and Other for the three months ended December 31, 2022 was $16.8 million, a decrease of $5.7 million, from operating loss of $22.5 million for the three months ended December 31, 2021. This change was primarily due to lower general and administrative expenses mainly on account of lower salaries, wages, and benefits.

Refer to Note 17, *Segment Information*, in the Notes to the Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q.

**Comparison of Six Months Ended December 31, 2022 to Six Months Ended December 31, 2021** 

***Consolidated Results***

The following table compares our results of operations, including as a percentage of net sales, on a consolidated basis, for the six months ended December 31, 2022 and 2021 (amounts in thousands, other than per share data and percentages, which may not add due to rounding):

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Six Months Ended** | **Six Months Ended** | **Six Months Ended** | **Six Months Ended** | **Change in** | **Change in** |
| | **December 31, 2022** | **December 31, 2022** | **December 31, 2021** | **December 31, 2021** | **Dollars** | **Percentage** |
| Net sales | $893559 | 100.0% | $931844 | 100.0% | $(38285) | (4.1)% |
| Cost of sales | 695367 | 77.8% | 709131 | 76.1% | (13764) | (1.9)% |
| Gross profit | 198192 | 22.2% | 222713 | 23.9% | (24521) | (11.0)% |
| Selling, general and administrative expenses | 147308 | 16.5% | 153929 | 16.5% | (6621) | (4.3)% |
| Amortization of acquired intangible assets | 5573 | 0.6% | 4144 | 0.4% | 1429 | 34.5% |
| Productivity and transformation costs | 1759 | 0.2% | 6769 | 0.7% | (5010) | (74.0)% |
| Long-lived asset impairment | 340 | —% | 303 | —% | 37 | 12.2% |
| Operating income | 43212 | 4.8% | 57568 | 6.2% | (14356) | (24.9)% |
| Interest and other financing expense, net | 18489 | 2.1% | 4448 | 0.5% | 14041 | 315.7% |
| Other income, net | (2852) | (0.3)% | (9858) | (1.1)% | 7006 | (71.1)% |
| Income before income taxes and equity in net loss of equity-method investees | 27575 | 3.1% | 62978 | 6.8% | (35403) | (56.2)% |
| Provision for income taxes | 8988 | 1.0% | 11687 | 1.3% | (2699) | (23.1)% |
| Equity in net loss of equity-method investees | 698 | 0.1% | 991 | 0.1% | (293) | (29.6)% |
| Net income | $17889 | 2.0% | $50300 | 5.4% | $(32411) | (64.4)% |
| Adjusted EBITDA | $85846 | 9.6% | $106580 | 11.4% | $(20734) | (19.5)% |
| Diluted net income per common share | $0.20 |  | $0.52 |  | $(0.32) | (61.5)% |

---

------

**<u>[Table of](#i7551ba622ce34f48a2da5a764b6c3dec_7)[Contents](#i7551ba622ce34f48a2da5a764b6c3dec_7)</u>**

<u>Net Sales</u>

Net sales for the six months ended December 31, 2022 were $893.6 million, a decrease of $38.3 million, or 4.1%, as compared to $931.8 million in the six months ended December 31, 2021. On a constant currency basis, adjusted for the impact of acquisitions, divestitures and discontinued brands, net sales decreased approximately $15.3 million, or 1.7%, from the prior comparable period primarily driven by International reportable segment. Further details of changes in net sales by segment are provided below in the *Segment Results* section.

<u>Gross Profit</u>

Gross profit for the six months ended December 31, 2022 was $198.2 million, a decrease of $24.5 million, or 11.0%, as compared to the prior year comparable period. Gross profit margin was 22.2% of net sales, compared to 23.9% in the prior year comparable period. The decrease in gross profit was driven primarily by the International reportable segment mainly due to lower net sales in the Europe and United Kingdom operating segments, higher energy and supply chain costs, as well as under absorption of overhead costs at our manufacturing facilities when compared to the prior year period. The North America reportable segment had an increase in gross profit mainly driven by pricing increases and cost improvements driven by higher productivity, partially offset by inflation and lower net sales in the Canada operating segment when compared with the prior year comparable period.

<u>Selling, General and Administrative Expenses</u>

Selling, general and administrative expenses were $147.3 million for the six months ended December 31, 2022, a decrease of $6.6 million, or 4.3%, from $153.9 million for the prior year comparable period. The decrease was primarily driven by reductions in Corporate and the International reportable segment. The decrease was driven by lower labor-related expenses primarily in Corporate and lower marketing costs, as well as efficiencies gained from the Company's productivity and transformation initiatives.

<u>Amortization of Acquired Intangible Assets</u>

Amortization of acquired intangibles was $5.6 million for the six months ended December 31, 2022, an increase of $1.4 million from $4.1 million in the prior year comparable period due to the acquisition of THWR in the second quarter of the prior fiscal year.

<u>Productivity and Transformation Costs</u>

Productivity and transformation costs were $1.8 million for the six months ended December 31, 2022, a decrease of $5.0 million from $6.8 million in the prior year comparable period. The decrease was primarily due to reduced spending related to productivity and transformation initiatives as the current transformation effort approaches its conclusion.

<u>Long-lived Asset Impairment</u> 

During the six months ended December 31, 2022, the Company recognized an impairment charge of $0.3 million relating to a facility in the United States. During the six months ended December 31, 2021, the Company recognized a pre-tax impairment charge of $0.3 million related to a facility in the United Kingdom.

<u>Operating Income</u>

Operating income for the six months ended December 31, 2022 was $43.2 million compared to $57.6 million in the prior year comparable period as a result of the items described above.

<u>Interest and Other Financing Expense, Net</u>

Interest and other financing expense, net totaled $18.5 million for the six months ended December 31, 2022, an increase of $14.0 million, or 315.7%, from $4.4 million in the prior year comparable period. The increase resulted primarily from a higher outstanding debt balance driven primarily by the acquisition of THWR in the second quarter of the prior fiscal year as well as share repurchase activity during fiscal 2022. Interest and other financing expense was also impacted by higher interest rates compared to the prior comparable period. See Note 9, *Debt and Borrowings*, in the Notes to the Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q.

------

**<u>[Table of](#i7551ba622ce34f48a2da5a764b6c3dec_7)[Contents](#i7551ba622ce34f48a2da5a764b6c3dec_7)</u>**

<u>Other Income, Net</u>

Other income, net totaled $2.9 million for the six months ended December 31, 2022, compared to $9.9 million in the prior year comparable period. The increase in income was primarily attributable to the gain on sale of assets related to the sale of undeveloped land plots in Boulder, Colorado resulting in a gain of $8.7 million in the prior year period.

<u>Income from Operations Before Income Taxes and Equity in Net Loss of Equity-Method Investees</u>

Income before income taxes and equity in net loss of our equity-method investees for the six months ended December 31, 2022 was income of $27.6 million compared to $63.0 million in the prior year comparable period. The decrease was due to the items discussed above.

<u>Provision for Income Taxes</u>

The provision for income taxes includes federal, foreign, state and local income taxes. Our income tax expense was $9.0 million for the six months ended December 31, 2022 compared to $11.7 million in the prior year comparable period.

The effective income tax rate was an expense of 32.6% and 18.6% for the six months ended December 31, 2022 and 2021, respectively. The effective income tax rate for the six months ended December 31, 2022 was impacted by the gain on sale of Westbrae, an operating lease modification during the second quarter, severance with respect to our former CEO (as part of the limitation on the deductibility of executive compensation), stock-based compensation and uncertain tax positions. The effective income tax rate for the six months ended December 31, 2021 was impacted by the reversal of uncertain tax position accruals based on filing of certain elections by taxing authorities, deductions related to stock-based compensation, non-deductible transaction costs related to the acquisition of THWR, and the reversal of a valuation allowance due to the utilization of a capital loss carryover. The effective income tax rates in each period were also impacted by the geographical mix of earnings and state income taxes.

<u>Equity in Net Loss of Equity-Method Investees</u>

Our equity in net loss from our equity-method investments for the six months ended December 31, 2022 was $0.7 million compared to $1.0 million in the prior year comparable period. See Note 13, *Investments*, in the Notes to the Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q.

<u>Net Income</u>

Net income for the six months ended December 31, 2022 was $17.9 million, or $0.20 per diluted share, compared to $50.3 million, or $0.52 per diluted share, in the prior year comparable period. The change was attributable to the factors noted above.

<u>Adjusted EBITDA</u>

Our Adjusted EBITDA was $85.8 million and $106.6 million for the six months ended December 31, 2022 and 2021, respectively, as a result of the factors discussed above, and the adjustments described in the *Reconciliation of Non-U.S. GAAP Financial Measures to U.S. GAAP Measures* presented following the discussion of our results of operations. On a constant currency basis, Adjusted EBITDA decreased by $15.2 million, or 14.3%, from $106.6 million for the six months ended December 31, 2021 to $91.4 million for the six months ended December 31, 2022.

------

**<u>[Table of](#i7551ba622ce34f48a2da5a764b6c3dec_7)[Contents](#i7551ba622ce34f48a2da5a764b6c3dec_7)</u>**

***Segment Results***

The following table provides a summary of net sales and operating income by reportable segment for the six months ended December 31, 2022 and 2021:

---

| | | | | |
|:---|:---|:---|:---|:---|
| *(dollars in thousands)* | **North America** | **International** | **Corporate and Other** | **Consolidated** |
| <u>Net sales</u> |  |  |  |  |
| Six months ended 12/31/22 | $570757 | $322802 | $— | $893559 |
| Six months ended 12/31/21 | 540539 | 391305 |  | 931844 |
| &nbsp;&nbsp;&nbsp;$ change | $30218 | $(68503) | n/a | $(38285) |
| &nbsp;&nbsp;&nbsp;% change | 5.6% | (17.5)% | n/a | (4.1)% |
| <u>Operating income (loss)</u> |  |  |  |  |
| Six months ended 12/31/22 | $56707 | $19615 | $(33110) | $43212 |
| Six months ended 12/31/21 | 44004 | 51437 | (37873) | 57568 |
| &nbsp;&nbsp;&nbsp;$ change | $12703 | $(31822) | $4763 | $(14356) |
| &nbsp;&nbsp;&nbsp;% change | 28.9% | (61.9)% | (12.6)% | (24.9)% |
| <u>Operating income margin</u> |  |  |  |  |
| Six months ended 12/31/22 | 9.9% | 6.1% | n/a | 4.8% |
| Six months ended 12/31/21 | 8.1% | 13.1% | n/a | 6.2% |

---

<u>North America</u>

Our net sales in the North America reportable segment for the six months ended December 31, 2022 were $570.8 million, an increase of $30.2 million, or 5.6%, from net sales of $540.5 million in the prior year comparable period. On a constant currency basis, adjusted for the impact of acquisitions, divestitures and discontinued brands, net sales increased by 0.7% due to increased sales in the United States operating segment due to stronger sales in snacks, partially offset by decreased sales in the Canada operating segment due to lower sales in personal care product categories. Operating income in North America for the six months ended December 31, 2022 was $56.7 million, an increase of $12.7 million from $44.0 million in the prior year comparable period. The increase was mainly driven by pricing increases, cost improvements driven by higher productivity, and lower marketing, partly offset by inflation, higher selling, general and administrative costs, and lower net sales in the Canada operating segment when compared with the prior year period.

<u>International</u> 

Our net sales in the International reportable segment for the six months ended December 31, 2022 were $322.8 million, a decrease of $68.5 million, or 17.5%, from net sales of $391.3 million in the prior year comparable period. On a constant currency basis, net sales decreased 4.8% from the prior year comparable period mainly due to lower sales in the Europe and United Kingdom operating segments. Operating income in our International reportable segment for the six months ended December 31, 2022 was $19.6 million, a decrease of $31.8 million from operating income of $51.4 million for the six months ended December 31, 2021. Operating income was lower in the current period when compared to the prior year comparable period mainly due to lower gross profit resulting from a decline in sales, higher energy and supply chain costs, as well as change in sales mix of high margin products.

------

**<u>[Table of](#i7551ba622ce34f48a2da5a764b6c3dec_7)[Contents](#i7551ba622ce34f48a2da5a764b6c3dec_7)</u>**

<u>Corporate and Other</u>

Our Corporate and Other category consists of expenses related to the Company's centralized administrative functions, which do not specifically relate to an operating segment. Such Corporate and Other expenses are comprised mainly of compensation and related expenses of certain of the Company's senior executive officers and other employees who perform duties related to our entire enterprise as well as expenses for certain professional fees, acquisition and divestiture transaction costs, facilities, and other items which benefit the Company as a whole. Our operating expenses in Corporate and Other for the six months ended December 31, 2022 were $33.1 million, a decrease of $4.8 million, from $37.9 million in the prior year period. This change was primarily due to lower general and administrative expenses.

Refer to Note 17, *Segment Information*, in the Notes to the Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q.

**Liquidity and Capital Resources** 

We finance our operations and growth primarily with the cash flows we generate from our operations and from borrowings available to us under our Credit Agreement (as defined below). We believe that our cash flows from operations and borrowing capacity under our Credit Agreement (as defined below) will be adequate to meet anticipated operating and other expenditures for the foreseeable future.

<u>Amended and Restated Credit Agreement</u>

On December 22, 2021, the Company refinanced its revolving credit facility by entering into a Fourth Amended and Restated Credit Agreement (as amended by a First Amendment dated December 16, 2022, the "Credit Agreement"). The Credit Agreement provides for senior secured financing of $1,100.0 million in the aggregate, consisting of (1) $300.0 million in aggregate principal amount of term loans (the "Term Loans") and (2) an $800.0 million senior secured revolving credit facility (which includes borrowing capacity available for letters of credit, and is comprised of a $440.0 million U.S. revolving credit facility and $360.0 million global revolving credit facility) (the "Revolver"). Both the Revolver and the Term Loans mature on December 22, 2026.

The Credit Agreement includes financial covenants that require compliance with a consolidated interest coverage ratio, a consolidated leverage ratio and a consolidated secured leverage ratio. The minimum consolidated interest coverage ratio is 2.75:1.00. The maximum consolidated leverage ratio is 6.00:1.00. Through December 31, 2023 or such earlier date as elected by the Company (the "Amendment Period"), the maximum consolidated secured leverage ratio is 5.00:1.00. Following the Amendment Period, the maximum consolidated secured leverage ratio will be 4.25:1.00, subject to possible temporary increase following certain corporate acquisitions.

During the Amendment Period, loans under the Credit Agreement will bear interest at (a) the Secured Overnight Financing Rate, plus a credit spread adjustment of 0.10% (as adjusted, "Term SOFR") plus 2.0% per annum or (b) the Base Rate (as defined in the Credit Agreement) plus 1.0% per annum. Following the Amendment Period, loans will bear interest at rates based on (a) Term SOFR plus a rate ranging from 0.875% to 1.750% per annum or (b) the Base Rate plus a rate ranging from 0.00% to 0.750% per annum, the relevant rate in each case being the Applicable Rate. The Applicable Rate following the Amendment Period will be determined in accordance with a leverage-based pricing grid, as set forth in the Credit Agreement. The weighted average interest rate on outstanding borrowings under the Credit Agreement at December 31, 2022 was 5.59%. Additionally, the Credit Agreement contains a Commitment Fee (as defined in the Credit Agreement) on the amount unused under the Credit Agreement ranging from 0.15% to 0.25% per annum, and such Commitment Fee is determined in accordance with a leverage-based pricing grid.

As of December 31, 2022, there were $587.0 million of loans under the Revolver, $292.5 million of Term Loans, and $6.8 million letters of credit outstanding under the Credit Agreement. As of December 31, 2022, $206.2 million was available under the Credit Agreement , subject to compliance with the financial covenants, as compared to $204.0 million as of June 30, 2022. As of December 31, 2022, the Company was in compliance with all associated covenants.

In addition to obligations under the Credit Agreement, we are party to other contractual obligations involving commitments to make payments to third parties, including purchase commitments and lease obligations, which impact our short-term and long-term liquidity and capital resource needs. See Note 7, Leases.

Our cash and cash equivalents balance decreased $22.1 million at December 31, 2022 to $43.4 million as compared to $65.5 million at June 30, 2022. Our working capital was $357.4 million at December 31, 2022, an increase of $28.4 million from

------

**<u>[Table of](#i7551ba622ce34f48a2da5a764b6c3dec_7)[Contents](#i7551ba622ce34f48a2da5a764b6c3dec_7)</u>**

$329.0 million at the end of fiscal 2022. Additionally, our total debt decreased by $10.2 million at December 31, 2022 to $878.4 million as compared to $888.6 million at June 30, 2022 as a result of $9.8 million of net repayments carried out during the period.

Our cash balances are held in the United States, United Kingdom, Canada, Europe, the Middle East and India. As of December 31, 2022, substantially all of the total cash balance from operations was held outside of the United States.

We maintain our cash and cash equivalents primarily in money market funds or their equivalent. As of December 31, 2022, all of our investments were expected to mature in less than three months. Accordingly, we do not believe that our investments have significant exposure to interest rate risk. Cash (used in) provided by operating, investing and financing activities is summarized below.

---

| | | | |
|:---|:---|:---|:---|
| | **Six Months Ended December 31,** | **Six Months Ended December 31,** | **Change in** |
| *(amounts in thousands)* | **2022** | **2021** | **Dollars** |
| <u>Cash flows (used in) provided by:</u> |  |  |  |
| Operating activities | $(2652) | $68031 | $(70683) |
| Investing activities | (6014) | (272345) | 266331 |
| Financing activities | (10892) | 208849 | (219741) |
| Effect of exchange rate changes on cash | (2517) | (3204) | 687 |
| Net increase in cash and cash equivalents | $(22075) | $1331 | $(23406) |

---

Cash used in operating activities was $2.7 million for the six months ended December 31, 2022, a decrease of $70.7 million from cash provided by operating activities of $68.0 million in the prior year period. This decrease versus the prior period resulted primarily from a reduction of $25.5 million in net income adjusted for non-cash charges in the current period and lower cash generation of $45.2 million from our working capital accounts primarily due to higher inventory balances as a result of inflation, and a higher account receivable balance due to timing of cash receipts.

Cash used in investing activities was $6.0 million for the six months ended December 31, 2022, a decrease of $266.3 million from $272.3 million in the prior year period primarily due to the acquisition of THWR in the same period of the prior year.

Cash used in financing activities was $10.9 million for the six months ended December 31, 2022, a decrease in cash provided of $219.7 million compared to $208.8 million of cash provided in the prior year period. The decrease in cash provided by financing activities is primarily due to higher borrowings under the Credit Agreement to finance the THWR acquisition, higher share repurchases, and payment of shares withheld for employee payroll taxes during the same period in the prior year.

<u>Operating Free Cash Flows</u>

Operating free cash flows were negative $16.7 million for the six months ended December 31, 2022, a decrease of $56.7 million from $40.0 million provided by operating free cash flows in the six months ended December 31, 2021. This decrease versus prior year resulted primarily from a decrease in cash flow from operations of $70.7 million driven by the reasons explained above. See the *Reconciliation of Non-U.S. GAAP Financial Measures to U.S. GAAP Measures* following the discussion of our results of operations for definitions and a reconciliation from our net cash provided by operating activities to operating free cash flows.

<u>Share Repurchase Program</u>

In January 2022, the Company's Board of Directors authorized the repurchase of up to $200.0 million of the Company's issued and outstanding common stock. Repurchases may be made from time to time in the open market, pursuant to pre-set trading plans, in private transactions or otherwise. The current 2022 authorization does not have a stated expiration date. The extent to which the Company repurchases its shares and the timing of such repurchases will depend upon market conditions and other corporate considerations. During the six months ended December 31, 2022, the Company did not repurchase any shares under the repurchase program. As of December 31, 2022, the Company had $173.5 million of remaining authorization under the share repurchase program.

------

**<u>[Table of](#i7551ba622ce34f48a2da5a764b6c3dec_7)[Contents](#i7551ba622ce34f48a2da5a764b6c3dec_7)</u>**

***Reconciliation of Non-U.S. GAAP Financial Measures to U.S. GAAP Measures***

We have included in this report measures of financial performance that are not defined by U.S. GAAP. We believe that these measures provide useful information to investors and include these measures in other communications to investors.

For each of these non-U.S. GAAP financial measures, we are providing below a reconciliation of the differences between the non-U.S. GAAP measure and the most directly comparable U.S. GAAP measure, an explanation of why our management and Board of Directors believe the non-U.S. GAAP measure provides useful information to investors and any additional purposes for which our management and Board of Directors use the non-U.S. GAAP measures. These non-U.S. GAAP measures should be viewed in addition to, and not in lieu of, the comparable U.S. GAAP measures.

<u>Net Sales - Constant Currency Presentation</u> 

We believe that net sales adjusted for the impact of foreign currency provides useful information to investors because it provides transparency to underlying performance in our consolidated net sales by excluding the effect that foreign currency exchange rate fluctuations have on year-to-year comparability given the volatility in foreign currency exchange markets. To present net sales adjusted for the impact of foreign currency, current period net sales for entities reporting in currencies other than the U.S. Dollar are translated into U.S. Dollars at the average monthly exchange rates in effect during the corresponding period of the prior fiscal year, rather than at the actual average monthly exchange rate in effect during the current period of the current fiscal year. As a result, the foreign currency impact is equal to the current year results in local currencies multiplied by the change in average foreign currency exchange rate between the current fiscal period and the corresponding period of the prior fiscal year.

<u>Net Sales - Adjusted for the Impact of Acquisitions, Divestitures and Discontinued Brands</u>

We also exclude the impact of acquisitions, divestitures and discontinued brands when comparing net sales to prior periods, which results in the presentation of certain non-U.S. GAAP financial measures. The Company's management believes that excluding the impact of acquisitions, divestitures and discontinued brands when presenting period-over-period results of net sales aids in comparability.

To present net sales adjusted for the impact of acquisitions, the net sales of an acquired business are excluded from fiscal quarters constituting or falling within the current period and prior period where the applicable fiscal quarter in the prior period did not include the acquired business for the entire quarter. To present net sales adjusted for the impact of divestitures and discontinued brands, the net sales of a divested business or discontinued brand are excluded from all periods.

A reconciliation between reported net sales and net sales adjusted for the impact of foreign currency, acquisitions, divestitures and discontinued brands is as follows:

------

**<u>[Table of](#i7551ba622ce34f48a2da5a764b6c3dec_7)[Contents](#i7551ba622ce34f48a2da5a764b6c3dec_7)</u>**

---

| | | | |
|:---|:---|:---|:---|
| *(amounts in thousands)* | **North America** | **International** | **Hain Consolidated** |
| Net sales - Three months ended December 31, 2022 | $282361 | $171847 | $454208 |
| Acquisitions, divestitures and discontinued brands | (16849) |  | (16849) |
| Impact of foreign currency exchange | 2075 | 23720 | 25795 |
| Net sales on a constant currency basis adjusted for acquisitions, divestitures and discontinued brands - Three months ended December 31, 2022 | $267587 | $195567 | $463154 |
| Net sales - Three months ended December 31, 2021 | $275014 | $201927 | $476941 |
| Acquisitions, divestitures and discontinued brands | (2280) |  | (2280) |
| Net sales adjusted for acquisitions, divestitures and discontinued brands - Three months ended December 31, 2021 | $272734 | $201927 | $474661 |
| Net sales growth (decline) | 2.7% | (14.9)% | (4.8)% |
| Impact of acquisitions, divestitures and discontinued brands | (5.4)% | —% | (3.0)% |
| Impact of foreign currency exchange | 0.8% | 11.7 | 5.4% |
| Net sales decline on a constant currency basis adjusted for acquisitions, divestitures and discontinued brands | (1.9)% | (3.2)% | (2.4)% |
| Net sales - Six months ended December 31, 2022 | $570757 | $322802 | $893559 |
| Acquisitions, divestitures and discontinued brands | (34499) |  | (34499) |
| Impact of foreign currency exchange | 3143 | 49506 | 52649 |
| Net sales on a constant currency basis adjusted for acquisitions, divestitures and discontinued brands - Six months ended December 31, 2022 | $539401 | $372308 | $911709 |
| Net sales - Six months ended December 31, 2021 | $540539 | $391305 | $931844 |
| Acquisitions, divestitures and discontinued brands | (4832) |  | (4832) |
| Net sales adjusted for acquisitions, divestitures and discontinued brands - Six months ended December 31, 2021 | $535707 | $391305 | $927012 |
| Net sales growth (decline) | 5.6% | (17.5)% | (4.1)% |
| Impact of acquisitions, divestitures and discontinued brands | (5.5)% | —% | (3.2)% |
| Impact of foreign currency exchange | 0.6% | 12.7% | 5.6% |
| Net sales growth (decline) on a constant currency basis adjusted for acquisitions, divestitures and discontinued brands | 0.7% | (4.8)% | (1.7)% |

---

<u>Adjusted EBITDA</u>

The Company defines Adjusted EBITDA as net income before net interest expense, income taxes, depreciation and amortization, equity in net loss of equity-method investees, stock-based compensation, net, unrealized currency losses (gains), certain litigation and related costs, CEO succession costs, plant closure related costs, net, productivity and transformation costs, warehouse and manufacturing consolidation and other costs, costs associated with acquisitions, divestitures and other transactions, gains on sales of assets, certain inventory write-downs, long-lived asset impairments and other adjustments. The Company's management believes that this presentation provides useful information to management, analysts and investors regarding certain additional financial and business trends relating to its results of operations and financial condition. In addition, management uses this measure for reviewing the financial results of the Company and as a component of performance-based executive compensation. Adjusted EBITDA is a non-U.S. GAAP measure and may not be comparable to similarly titled measures reported by other companies.

------

**<u>[Table of](#i7551ba622ce34f48a2da5a764b6c3dec_7)[Contents](#i7551ba622ce34f48a2da5a764b6c3dec_7)</u>**

We do not consider Adjusted EBITDA in isolation or as an alternative to financial measures determined in accordance with U.S. GAAP. The principal limitation of Adjusted EBITDA is that it excludes certain expenses and income that are required by U.S. GAAP to be recorded in our consolidated financial statements. In addition, Adjusted EBITDA is subject to inherent limitations as this metric reflects the exercise of judgment by management about which expenses and income are excluded or included in determining Adjusted EBITDA. In order to compensate for these limitations, management presents Adjusted EBITDA in connection with U.S. GAAP results. A reconciliation of net income (loss) to Adjusted EBITDA is as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended December 31,** | **Three Months Ended December 31,** | **Six Months Ended December 31,** | **Six Months Ended December 31,** |
| *(amounts in thousands)* | **2022** | **2021** | **2022** | **2021** |
| Net income | $10966 | $30889 | $17889 | $50300 |
| Depreciation and amortization | 12155 | 10903 | 24125 | 21758 |
| Equity in net loss of equity-method investees | 316 | 465 | 698 | 991 |
| Interest expense, net | 10379 | 1685 | 17658 | 2831 |
| Provision for income taxes | 6357 | 7145 | 8988 | 11687 |
| Stock-based compensation, net | 3435 | 4156 | 7429 | 8443 |
| Unrealized currency losses (gains) | 2160 | (480) | 449 | (1503) |
| Litigation and related costs |  |  |  |  |
| &nbsp;&nbsp;Certain litigation expenses, net<sup>(a)</sup> | 2482 | 1624 | 4945 | 3384 |
| Restructuring activities |  |  |  |  |
| &nbsp;&nbsp;CEO succession | 5113 |  | 5113 |  |
| &nbsp;&nbsp;Plant closure related costs, net | 53 | (183) | 51 | 813 |
| &nbsp;&nbsp;Productivity and transformation costs | 986 | 2247 | 1759 | 5451 |
| &nbsp;&nbsp;Warehouse/manufacturing consolidation and other costs, net | (1972) | 249 | (1972) | 2538 |
| Acquisitions, divestitures and other |  |  |  |  |
| &nbsp;&nbsp;Transaction and integration costs, net | 402 | 8963 | 1769 | 8732 |
| &nbsp;&nbsp;Gain on sale of assets | (3355) | (8656) | (3395) | (9102) |
| Impairment charges |  |  |  |  |
| &nbsp;&nbsp;Inventory write-down |  | (46) |  | (46) |
| &nbsp;&nbsp;Long-lived asset impairment | 340 | 303 | 340 | 303 |
| Adjusted EBITDA | $49817 | $59264 | $85846 | $106580 |

---

<sup>(a)</sup> *Expenses and items relating to securities class action and baby food litigation.*

<u>Adjusted EBITDA - Constant Currency Presentation</u> 

The Company provides Adjusted EBITDA and Adjusted EBITDA on a constant currency basis because the Company's management believes that these presentations provide useful information to management, analysts and investors regarding certain additional financial and business trends relating to its results of operations and financial condition. In addition, management uses these measures for reviewing the financial results of the Company as well as a component of performance-based executive compensation. The Company believes presenting Adjusted EBITDA on a constant currency basis provides useful information to investors because it provides transparency to underlying performance in the Company's Adjusted EBITDA by excluding the effect that foreign currency exchange rate fluctuations have on period-to-period comparability given the volatility in foreign currency exchange markets.

------

**<u>[Table of](#i7551ba622ce34f48a2da5a764b6c3dec_7)[Contents](#i7551ba622ce34f48a2da5a764b6c3dec_7)</u>**

A reconciliation between Adjusted EBITDA and constant currency Adjusted EBITDA for the three months ended December 31, 2022 and 2021 is as follows:

---

| | |
|:---|:---|
| *(amounts in thousands)* | **Hain Consolidated** |
| Adjusted EBITDA - Three months ended December 31, 2022 | $49817 |
| Impact of foreign currency exchange | 2909 |
| Adjusted EBITDA on a constant currency basis - Three months ended December 31, 2022 | $52726 |
| Adjusted EBITDA - Three months ended December 31, 2021 | $59264 |

---

A reconciliation between Adjusted EBITDA and constant currency Adjusted EBITDA for the six months ended December 31, 2022 and 2021 is as follows:

---

| | |
|:---|:---|
| *(amounts in thousands)* | **Hain Consolidated** |
| Adjusted EBITDA - Six months ended December 31, 2022 | $85846 |
| Impact of foreign currency exchange | 5527 |
| Adjusted EBITDA on a constant currency basis - Six months ended December 31, 2022 | $91373 |
| Adjusted EBITDA - Six months ended December 31, 2021 | $106580 |

---

<u>Operating Free Cash Flows</u>

In our internal evaluations, we use the non-U.S. GAAP financial measure "Operating Free Cash Flows" The difference between Operating Free Cash Flows and cash flow provided by or used in operating activities, which is the most comparable U.S. GAAP financial measure, is that Operating Free Cash Flows reflects the impact of purchases of property, plant and equipment (capital spending). Since capital spending is essential to maintaining our operational capabilities, we believe that it is a recurring and necessary use of cash. As such, we believe investors should also consider capital spending when evaluating our cash provided by or used in operating activities. We view Operating Free Cash Flows as an important measure because it is one factor in evaluating the amount of cash available for discretionary investments. We do not consider Operating Free Cash Flows in isolation or as an alternative to financial measures determined in accordance with U.S. GAAP.

A reconciliation from cash flows (used in) provided by operating activities to Operating Free Cash Flows is as follows:

---

| | | |
|:---|:---|:---|
| | **Six Months Ended December 31,** | **Six Months Ended December 31,** |
| *(amounts in thousands)* | **2022** | **2021** |
| Net cash (used in) provided by operating activities | $(2652) | $68031 |
| Purchases of property, plant and equipment | (14055) | (27996) |
| Operating free cash flows | $(16707) | $40035 |

---

------

**<u>[Table of](#i7551ba622ce34f48a2da5a764b6c3dec_7)[Contents](#i7551ba622ce34f48a2da5a764b6c3dec_7)</u>**

**Critical Accounting Estimates**

Our financial statements are prepared in accordance with accounting principles generally accepted in the United States. The accounting principles we use require us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and amounts of income and expenses during the reporting periods presented. We believe in the quality and reasonableness of our critical accounting policies; however, materially different amounts may be reported under different conditions or using assumptions different from those that we have applied. The accounting policies that have been identified as critical to our business operations and to understanding the results of our operations pertain to variable consideration, valuation of accounts and chargeback receivable, valuation of long-lived assets, goodwill and intangible assets, stock-based compensation and valuation allowances for deferred tax assets. The application of each of these critical accounting policies and estimates is discussed in Part II, Item 7, *Management's Discussion and Analysis of Financial Condition and Results of Operations*, of our Annual Report on Form 10-K for the fiscal year ended June 30, 2022 from which there have been no material changes.

**Recent Accounting Pronouncements** 

Refer to Note 2, *Basis of Presentation*, in the Notes to the Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q.

**Seasonality**

Certain of our product lines have seasonal fluctuations. Hot tea, hot-eating desserts and soup sales are stronger in colder months, while sales of snack foods, sunscreen and certain of our personal care products are stronger in the warmer months. As such, our results of operations and our cash flows for any particular quarter are not indicative of the results we expect for the full year, and our historical seasonality may not be indicative of future quarterly results of operations. In recent years, net sales and diluted earnings per share in the first fiscal quarter have typically been the lowest of our four quarters.

**Item 3. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Quantitative and Qualitative Disclosures About Market Risk**

There have been no significant changes in market risk from those addressed in the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2022 during the six months ended December 31, 2022. See the information set forth in Part II, Item 7A, *Quantitative and Qualitative Disclosures About Market Risk*, of the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2022.

------

**<u>[Table of](#i7551ba622ce34f48a2da5a764b6c3dec_7)[Contents](#i7551ba622ce34f48a2da5a764b6c3dec_7)</u>**

**Item 4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Controls and Procedures** 

**Evaluation of Disclosure Controls and Procedures**

Our Chief Executive Officer ("CEO") and Chief Financial Officer ("CFO"), with the assistance of other members of management, have reviewed the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report. Our disclosure controls and procedures are intended to ensure that information required to be disclosed by the Company in the reports it files or submits under the Exchange Act is (1) recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission's rules and forms and (2) accumulated and communicated to our management, including our CEO and CFO, as appropriate to allow timely decisions regarding required disclosure. Based on this review, our CEO and CFO have concluded that the disclosure controls and procedures for the Company were effective as of December 31, 2022.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect every misstatement. An evaluation of effectiveness is subject to the risk that the controls may become inadequate because of changes in conditions, or that the degree of compliance with policies or procedures may decrease over time.

**Changes in Internal Control Over Financial Reporting**

There were no changes in our internal controls over financial reporting that occurred during the quarter ended December 31, 2022 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

------

**<u>[Table of](#i7551ba622ce34f48a2da5a764b6c3dec_7)[Contents](#i7551ba622ce34f48a2da5a764b6c3dec_7)</u>**

**PART II - OTHER INFORMATION**

**Item 1.**&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Legal Proceedings**

The information called for by this item is incorporated herein by reference to Note 16, *Commitments and Contingencies*, in the Notes to the Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q.

**Item 1A.**&nbsp;&nbsp;&nbsp;&nbsp;**Risk Factors** 

There have been no material changes from the discussion of the material factors that make an investment in the Company speculative or risky contained in the section entitled "Risk Factors" in the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2022, filed with the SEC on August 25, 2022.

**Item 2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unregistered Sales of Equity Securities and Use of Proceeds**

**Issuer Purchases of Equity Securities**

The table below sets forth information regarding repurchases by the Company of its common stock during the periods indicated.

---

| | | | | |
|:---|:---|:---|:---|:---|
| <u>Period</u> | (a)<br>Total number<br>of shares<br>purchased (1) | (b)<br>Average<br>price paid<br>per share | (c)<br>Total number of<br>shares purchased<br>as part of<br>publicly<br>announced plans | (d)<br>Maximum<br>number of shares<br>that may yet be<br>purchased under<br>the plans (in millions of dollars) (2) |
| October 1, 2022 - October 31, 2022 | (6143) | $(16.88) |  | $173.5 |
| November 1, 2022 - November 30, 2022 | (31677) | (20.15) |  | $173.5 |
| December 1, 2022 - December 31, 2022 | (723) | (16.18) |  | $173.5 |
| Total | (38543) | $(19.55) |  |  |

---

*(1) Consists of shares surrendered for payment of employee payroll taxes due on shares issued under stock-based compensation plans.*

*(2) In January 2022, the Company's Board of Directors authorized the repurchase of up to $200 million of the Company's issued and outstanding common stock. Repurchases may be made from time to time in the open market, pursuant to pre-set trading plans, in private transactions or otherwise. The authorization does not have a stated expiration date. The extent to which the Company repurchases its shares and the timing of such repurchases will depend upon market conditions, and other corporate considerations. During the quarter ended December 31, 2022, the Company did not repurchase any shares under the repurchase program. As of December 31, 2022, the Company had $173.5 million of remaining authorization under the share repurchase program.* 

**Item 5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other Information** 

Effective February 6, 2023, the Company's Board of Directors approved the elimination of the position of Executive Vice President and Chief Operating Officer as part of a management restructure of the Company's executive leadership team. Accordingly, David J. Karch, the Company's current Executive Vice President and Chief Operating Officer, left the Company effective February 6, 2023. Mr. Karch's responsibilities will be assumed by other members of the Company's executive leadership team.

Mr. Karch is entitled to receive the cash severance that is payable under the terms of his Amended and Restated Letter of Employment, dated March 18, 2021, upon a termination of his employment by the Company without cause, subject to his execution of a separation agreement and release of claims. Additionally, a prorated portion of Mr. Karch's November 2021 award of 52,109 special recognition restricted share units vested on February 6, 2023 in accordance with the terms of that award for a termination of employment by the Company without cause.

------

**<u>[Table of](#i7551ba622ce34f48a2da5a764b6c3dec_7)[Contents](#i7551ba622ce34f48a2da5a764b6c3dec_7)</u>**

**Item 6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exhibits**

---

| | |
|:---|:---|
| **Exhibit**<br>**Number** | **Description** |
| <u>[3.1](http://www.sec.gov/Archives/edgar/data/910406/0000912057-00-019377-index.html)</u> | <u>[Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 of the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2021, filed with the SEC on August 26, 2021).](http://www.sec.gov/Archives/edgar/data/910406/000091040621000033/exh31-restatedcertificateo.htm)</u> |
| <u>[3.](http://www.sec.gov/Archives/edgar/data/910406/000091040618000091/exhibit31amendedandrestate.htm)</u>2 | <u>[Amended and Restated By-Laws (incorporated by reference to Exhibit 3.1 of the Company's Current Report on Form 8-K filed with the SEC on December 7, 2018).](http://www.sec.gov/Archives/edgar/data/910406/000091040618000091/exhibit31amendedandrestate.htm)</u> |
| <u>[4.1](http://www.sec.gov/Archives/edgar/data/910406/0000912057-00-019377-index.html)</u> | <u>[Specimen of common stock certificate (incorporated by reference to Exhibit 4.1 of Amendment No. 1 to the Company's Registration Statement on Form S-4 filed with the SEC on April 24, 2000).](http://www.sec.gov/Archives/edgar/data/910406/0000912057-00-019377-index.html)</u> |
| <u>[10.1](https://www.sec.gov/Archives/edgar/data/910406/000119312522309599/d423508dex101.htm)</u> | <u>[First Amendment, dated December 16, 2022, to the Fourth Amended and Restated Credit Agreement, dated December 22, 2021, by and among the Company, the Lenders party thereto and Bank of America, N.A., as administrative agent (incorporated by reference to Exhibit 10.1 of the Company's Current Report on Form 8-K filed with the SEC on December 21, 2022).](https://www.sec.gov/Archives/edgar/data/910406/000119312522309599/d423508dex101.htm)</u> |
| <u>[10.2](https://www.sec.gov/Archives/edgar/data/910406/000119312522287646/d421002dex101.htm)</u>\* | <u>[The Hain Celestial Group, Inc. 2022 Long Term Incentive and Stock Award Plan (incorporated by reference to Exhibit 10.1 of the Company's Registration Statement on Form S-8 (Commission File No. 333-268439) filed with the Securities and Exchange Commission on November 17, 2022).](https://www.sec.gov/Archives/edgar/data/910406/000119312522287646/d421002dex101.htm)</u> |
| <u>[10.3](https://www.sec.gov/Archives/edgar/data/910406/000119312522292943/d402070dex101.htm)</u>\* | <u>[Employment Agreement, dated as of November 22, 2022, by and between The Hain Celestial Group, Inc. and Wendy Davidson (incorporated by reference to Exhibit 10.1 of the Company's Current Report on Form 8-K filed with the SEC on November 28, 2022).](https://www.sec.gov/Archives/edgar/data/910406/000119312522292943/d402070dex101.htm)</u> |
| <u>[10.4](exhhibit104-schillersepara.htm)</u>\* | <u>[Separation Agreement, dated December 31, 2022, between the Company and Mark L. Schiller.](exhhibit104-schillersepara.htm)</u> |
| <u>[31.1](hain-1231202210qxex311.htm)</u> | <u>[Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act, as amended.](hain-1231202210qxex311.htm)</u> |
| <u>[31.2](hain-1231202210qxex312.htm)</u> | <u>[Certification of Chief Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act, as amended.](hain-1231202210qxex312.htm)</u> |
| <u>[32.1](hain-1231202210qxex321.htm)</u> | <u>[Certification by Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](hain-1231202210qxex321.htm)</u> |
| <u>[32.2](hain-1231202210qxex322.htm)</u> | <u>[Certification by Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](hain-1231202210qxex322.htm)</u> |
| 101.INS | XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document. |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document. |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document. |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document. |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document. |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). |

---

\*Indicates management contract or compensatory plan or arrangement.

The agreements and other documents filed as exhibits to this report are not intended to provide factual information or other disclosure other than with respect to the terms of the agreements or other documents themselves, and you should not rely on them for that purpose. In particular, any representations and warranties made by us in these agreements or other documents were made solely within the specific context of the relevant agreement or document and may not describe the actual state of affairs as of the date they were made or at any other time.

------

**<u>[Table of](#i7551ba622ce34f48a2da5a764b6c3dec_7)[Contents](#i7551ba622ce34f48a2da5a764b6c3dec_7)</u>**

**<u>SIGNATURES</u>**

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | |
|:---|:---|:---|
| | | **THE HAIN CELESTIAL GROUP, INC.** |
| | | (Registrant) |
| Date: | February 7, 2023 | /s/&nbsp;&nbsp;&nbsp;&nbsp;Wendy P. Davidson |
| | | **Wendy P. Davidson,<br>President and<br>Chief Executive Officer** |

---

---

| | | |
|:---|:---|:---|
| Date: | February 7, 2023 | /s/ Christopher J. Bellairs |
| | | **Christopher J. Bellairs,<br>Executive Vice President and<br>Chief Financial Officer<br>(Principal Financial Officer and <br>Principal Accounting Officer)** |

---

## Exhibit 10.4

**Exhibit 10.4**

<u>SEPARATION AGREEMENT AND GENERAL RELEASE</u>

This Separation Agreement and General Release (this "Agreement") is made and entered into this 31st day of December, 2022 by and between The Hain Celestial Group, Inc. ("Hain" or the "Company") and Mark L. Schiller ("Employee").

WHEREAS, Hain and Employee are parties to an Employment Agreement, dated as of October 26, 2018 (the "Employment Agreement"); and

WHEREAS, Hain and Employee wish to amicably terminate Employee's employment with Hain;

NOW, THEREFORE, in consideration of the mutual promises and covenants set forth therein, Hain and Employee agree as follows:

1.<u>Termination of Employment</u>

Employee's last day of employment with Hain is December 31, 2022 (the "Termination Date").

2.<u>Severance Payments by Hain</u>

As consideration for signing this Agreement and Employee's complete compliance therewith, Hain shall provide Employee with cash severance in the aggregate amount of $4,725,000 (equal to two (2) times the sum of Employee's annual base salary plus Employee's target annual bonus as of the Termination Date), less applicable withholdings and deductions, payable over a period of two (2) years starting from the Effective Date (as defined below), payable in biweekly installments in accordance with the general payroll practices of the Company. This severance is in accordance with the severance obligation provided in Paragraph 11.b of the Employment Agreement in the event of a termination by the Company without Cause.

3.<u>Prorated Fiscal Year 2023 Bonus</u>

Employee shall be eligible to receive a prorated annual bonus under the Company's Fiscal Year 2023 Annual Incentive Plan (the "2023 AIP"). The prorated target bonus amount shall be $656,250 (the "FY23 Prorated Target Bonus Amount"), which is equal to fifty percent (50%) of Employee's target annual bonus amount under the 2023 AIP in effect prior to the entry into this Agreement, based on the amount of time Employee served as an employee of the Company during the Company's fiscal year 2023. The prorated bonus opportunity under the 2023 AIP shall not be subject to an individual performance component, such that Employee shall receive a payout equal to the percentage payout based on Company performance during the full fiscal year 2023 against the applicable Company performance targets under the 2023 AIP multiplied by the FY23 Prorated Target Bonus Amount. Any payout of a prorated annual bonus under this Section shall be made on or about the date that payouts under the 2023 AIP are made to employees, is subject to all other terms and conditions of the 2023 AIP and is subject to determinations thereunder by the Compensation Committee of the Company's Board of Directors in its reasonable discretion.

------

4.<u>Treatment of Outstanding Equity Awards</u>

The following equity awards held by Employee shall terminate in accordance with their terms as of the Termination Date: (A) 32,696 restricted share units ("RSUs") granted on November 18, 2021 (in an original award amount of 49,044 RSUs, of which 16,348 RSUs vested on November 18, 2022), (B) 49,289 performance share units ("PSUs") granted on November 18, 2021, (C) 24,277 PSUs granted on November 18, 2021 and (D) 80,172 RSUs granted on September 8, 2022.

In furtherance of the mutual desire of the Company and Employee to ensure a smooth transition of Employee's responsibilities to the successor President and Chief Executive Officer, to be accomplished in part through Employee's continued service on the Board as contemplated in Section 7 below, the following equity awards held by Employee shall remain partially outstanding following the Termination Date on a prorated basis in accordance with this paragraph: (A) 80,572 PSUs granted on September 8, 2022 (the "FY23 LTIP Relative TSR PSUs"), and (B) 39,685 PSUs granted on September 8, 2022 (the "FY23 LTIP Absolute TSR PSUs," and together with the FY23 LTIP Relative TSR PSUs, the "FY23 LTIP PSUs"). The FY23 LTIP PSUs shall be prorated fifty percent (50%) based on the amount of time Employee served as an employee of the Company during the Company's fiscal year 2023, such that as of the Termination Date the Target Number of PSUs (as defined in the award agreement) under the FY23 LTIP Relative TSR PSUs shall be 40,286 PSUs and the Target Number of PSUs (as defined in the award agreement) under the FY23 LTIP Absolute TSR PSUs shall be 19,843 PSUs. All other terms and conditions of the FY23 LTIP PSUs shall remain in effect, provided that the time-based vesting conditions set forth in Section 4.3 of the respective award agreements shall no longer apply, and instead the following time-based vesting condition shall apply:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A)If Employee serves as a member of the Company's Board of Directors until the earlier of (i) the date of the Company's 2023 annual meeting of stockholders or (ii) any earlier date mutually agreed between Employee and the Company's Board of Directors for Employee's departure from the Board of Directors, then the time-based vesting condition shall be satisfied;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;B)If, prior to the date of the Company's 2023 annual meeting of stockholders, Employee's service on the Company's Board of Directors ends by reason of death or Disability (as defined in the award agreements), then the time-based vesting condition shall be satisfied; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;C)If, prior to the date of the Company's 2023 annual meeting of stockholders, Employee's service on the Company's Board of Directors ends in connection with a Change in Control (as defined in the award agreements), then the time-based vesting condition shall be satisfied.

For the avoidance of doubt, in addition to the above time-based vesting condition, any future vesting of the FY23 LTIP PSUs is subject to attainment during the Performance Period (ending September 6, 2025 or the effective date of any earlier Change in Control, as defined in the award agreements) of the performance goals set forth in the award agreements and all other terms and conditions set forth in the award agreements.

5.<u>Benefits</u>

Following the Termination Date, Employee will be eligible to elect to continue medical, dental and vision plan coverage pursuant to the notice sent to Employee by the Company's insurance provider in accordance with the Consolidated Omnibus Budget Reconciliation Act ("COBRA"). If Employee properly and timely

------

elects medical, dental, and/or vision coverage pursuant to COBRA as coverage existed as of the Termination Date, Hain agrees to pay the cost of the premium for such elected coverage (subject to applicable taxes) for the entire 18-month COBRA period, beginning on January 1, 2023 and ending June 30, 2024, provided Employee remains eligible for COBRA coverage continuation. From July 1, 2024 through December 31, 2024, the Company will reimburse Employee for the cost of any private medical, dental and vision coverage procured by Employee that is substantially similar to the coverage that Employee elected as of the Termination Date.

Employee's participation in all other benefits and incidents of employment (including, but not limited to, the accrual of vacation and paid time off, Life Insurance, AD&D, Long Term Disability, 401(k), and the vesting of equity grants as applicable) cease on the Termination Date.

6.<u>No Further Payment of Salary, Bonuses or Other Benefits or Compensation</u>

Except with respect to (A) the severance payments provided by Section 2 hereof, (B) the prorated annual bonus opportunity under the 2023 AIP provided by Section 3 hereof, (C) the prorated continuation of the FY23 LTIP PSUs provided by the second paragraph of Section 4 hereof, (D) the benefits provided by Section 5 hereof and (E) accrued vacation through the Termination Date (which accrued and unused vacation will be paid to Employee in accordance with the Company's standard policy and practices), Employee acknowledges and represents that, as of the date Employee signed this Agreement, Hain has paid all salary, wages, bonuses, equity, housing allowances, relocation costs, interest, severance, stock, fees, commissions, and any and all other benefits and compensation due to Employee.

7.<u>Continuing Service on Board of Directors</u>

Employee will continue to be a member of the Company's Board of Directors following the Termination Date, notwithstanding the last sentence of Section 2 of the Employment Agreement. There are no agreements or understandings with respect to Employee's nomination for election to the Board of Directors at future annual meetings of stockholders of the Company. Employee hereby waives the right to receive any compensation under the Company's compensation program for non-employee directors through the date of the Company's 2023 annual meeting of stockholders.

8.<u>Indemnification</u>

Notwithstanding anything to the contrary herein, including any release by Employee herein, to the fullest extent permitted by applicable law and the provisions of the existing Hain Certificate of Incorporation, Hain shall indemnify and hold harmless Employee from and against any and all liabilities, obligations, losses, damages, fines, taxes and interest and penalties thereon (other than taxes based on fees or other compensation received by Employee), claims, demands, actions, suits, proceedings (whether civil, criminal, administrative, investigative or otherwise), costs, expenses and disbursements (including legal and accounting fees and expenses, costs of investigation and sums paid in settlement) of any kind or nature whatsoever (collectively, "Claims and Expenses") which may be imposed on, incurred by or asserted at any time against Employee in any way related to Employee's employment by Hain, or the management or administration of Hain, or in connection with the business or affairs of Hain or the activities of Employee on behalf of the Company; <u>provided</u> that Employee shall not be entitled to indemnification hereunder for Claims and Expenses that are (i) incurred by Employee as plaintiff in any action, suit or proceeding brought against the Company or (ii) incurred by Employee as a

------

defendant in any action, suit or proceeding brought against Employee by a third party and found by a court of competent jurisdiction in a final judgment not subject to further appeal to be attributable to Employee's fraud, gross negligence or willful misconduct.

9.<u>Release by Employee</u>

Employee agrees that Employee would not be entitled to the consideration and benefits set forth in Sections 2 through 5 hereof absent Employee's execution and fulfillment of this Agreement. As a consequence of execution of this Agreement, Hain and its current and former officers, directors, employees, agents, investors, attorneys, creditors, counsel, shareholders, administrators, affiliates, divisions, subsidiaries, predecessor and successor corporations and assigns and any other affiliated or related person or entity (the "Releasees") have no outstanding obligations to Employee. Employee, on Employee's own behalf, and on behalf of Employee's present and former heirs, family members, executors, creditors, agents, assigns and any other affiliated or related person or entity, hereby fully and forever releases Hain and the other Releasees from, and agrees not to sue concerning, any claim, duty, obligation or cause of action relating to any matters of any kind, whether presently known or unknown, suspected or unsuspected, that Employee may possess up to and including the Effective Date of this Agreement, including, without limitation:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.any and all claims relating to or arising from Employee's employment with Hain, or the termination of that employment;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.any and all claims relating to, or arising from, Employee's right to purchase, or actual purchase of, shares of Company stock, including, but not limited to, any claims for fraud, misrepresentation, breach of fiduciary duty, breach of duty under applicable state corporate law, and securities fraud under any state or federal law;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.any and all claims under the law of any jurisdiction, including, but not limited to, wrongful discharge of employment; constructive discharge from employment; termination in violation of public policy; discrimination; breach of contract, both express and implied; breach of a covenant of good faith and fair dealing, both express and implied; promissory estoppel; negligent or intentional infliction of emotional distress; negligent or intentional misrepresentation; negligent or intentional interference with contract or prospective economic advantage; unfair business practices; defamation; libel; slander; negligence; personal injury; assault; qui tam; whistleblower, battery; invasion of privacy; false imprisonment; and conversion;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.any and all claims for violation of any federal, state or municipal statute, including, but not limited to, Title VII of the Civil Rights Act of 1964; the Civil Rights Act of 1991; the Age Discrimination in Employment Act of 1967; the Americans with Disabilities Act of 1990; the Employee Retirement Income Security Act of 1974; the Worker Adjustment and Retraining Notification Act; the Older Workers Benefit Protection Act; the Family and Medical Leave Act; the Fair Credit Reporting Act; the New York State Executive Law (including its Human Rights Law); the New York City Administrative Code (including its Human Rights Law); the New York State Labor Law; the New York wage, wage payment, wage theft and wage-hour laws; and the Sarbanes-Oxley Act;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e.any and all claims for violation of the federal, or any state, constitution;

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;f.any and all claims arising out of any other laws and regulations relating to employment or employment discrimination;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;g.any claim for any loss, cost, damage, or expense arising out of any dispute over the non-withholding or other tax treatment of any of the proceeds received by Employee as a result of this Agreement; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;h.any and all claims for attorneys' fees and costs.

Hain and Employee agree that the release set forth in this Section shall be and remain in effect in all respects as a complete general release as to the matters released for all time. Employee agrees and understands this Agreement provides a full and final general release covering all known and unknown and anticipated and unanticipated injuries, debts, or damages which may have arisen, or which may arise, connected with all matters from the beginning of time to the Effective Date, as well as those injuries, debts, claims or damages now known or disclosed which may have arisen, or which may arise, from Employee's employment with or separation from Hain on the Termination Date.

This release is not intended to bar claims for workers' compensation benefits or unemployment insurance benefits, but Employee acknowledges that Employee is not aware of any work-related condition or injury. Moreover, Employee and Hain acknowledge that this Agreement does not limit either party's right, where applicable, to file or participate in an investigation, hearing, whistleblower proceeding, or other federal, state or local governmental agency ("Governmental Agency") proceeding, but Employee waives the right to any personal remedy, to the maximum extent permitted by law, except that this Agreement does not limit Employee's right to receive an award for information provided to any Governmental Agency.

10.<u>Acknowledgement of Waiver of Claims Under ADEA</u>

Employee acknowledges that Employee is waiving and releasing any rights Employee may have under the Age Discrimination in Employment Act of 1967 ("ADEA") and that this waiver and release is knowing and voluntary. Employee and Hain agree that this waiver and release does not apply to any rights or claims that may arise under the ADEA after the Effective Date of this Agreement. Employee acknowledges that the consideration given for this waiver and release is in addition to anything of value to which Employee was already entitled. Employee further acknowledges that Employee has been advised by this writing that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.Employee should consult with an attorney prior to executing this Agreement;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Employee has up to twenty-one (21) days within which to consider this Agreement;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Employee has seven (7) days following Employee's execution of this Agreement to revoke this Agreement;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.this Agreement shall not be effective until the revocation period has expired; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e.nothing in this Agreement prevents or precludes Employee from challenging or seeking a determination in good faith of the validity of this waiver under the ADEA, nor does it impose any condition precedent, penalties or costs for doing so, unless specifically authorized by federal

------

law. However, if the release of ADEA claims or any other claim is set aside or limited, all monies paid hereunder shall be set-off against any relief or recovery.

11.<u>No Admission of Liability</u>

Neither this Agreement, nor anything contained herein, shall be construed as an admission by the Company that it has in any respect violated or abridged any Federal, State, or local law or any right or obligation that it may owe or may have owed to Employee. No final findings or final judgments have been made and Employee does not purport and will not claim to be a prevailing party, to any degree or extent, nor will this Agreement or its terms be admissible in any proceeding other than in a proceeding for breach of the terms contained herein.

12.<u>Cooperation by Employee</u>

To the maximum extent permitted by law, Employee shall assist Hain in the presentation or prosecution of any disputes, differences, grievances, claims, charges, or complaints by any third party against Hain or any of the Releasees without additional compensation, provided, however that Hain will reimburse Employee for reasonable out-of-pocket and travel-related expenses incurred with providing such assistance. Employee and Hain acknowledge this Section does not limit the right, where applicable, to file or participate in an investigative proceeding of any Governmental Agency without requiring notice to Hain or any of the Releasees; Employee nevertheless understands that because of the waiver and general release Employee freely provides by signing this Agreement, Employee cannot obtain any monetary relief or recovery in any such proceeding to the extent permitted by law, except that this Agreement does not limit Employee's right to receive an award for information provided to any Governmental Agency, as set forth in Section 9.

13.<u>Confidential and Proprietary Information of Hain</u>

In accordance with Section 12 of the Employment Agreement, Employee understands and agrees that all books, records, documents and information, whether written or not, pertaining to Hain's business activities, are the confidential and proprietary property of Hain (hereinafter referred to as "trade secrets and confidential and proprietary information") and must be returned in full and without retention of copies. Employee warrants, covenants, and agrees that Employee will not disclose any of Hain's trade secrets and confidential and proprietary information to any person or entity not employed, owned by, or otherwise affiliated with Hain or use such information for Employee's own benefit or the benefit of any person or entity not employed, owned by, or otherwise affiliated with Hain. Employee further agrees that Employee shall not be entitled to copies, in any form, of such trade secrets and confidential and proprietary information and Employee shall immediately return to Hain any copies of such information currently in Employee's possession or control. Notwithstanding the foregoing, nothing in this Agreement shall be construed to limit Employee from disclosing Employee's own wages or other employment terms as provided by law.

Notwithstanding anything herein to the contrary, this Agreement does not limit or interfere with Employee's right, without notice to or authorization of the Company, to communicate and cooperate in good faith with any self-regulatory organization or U.S. federal, state, or local governmental or law enforcement branch, agency, commission, or entity (collectively, a "Government Entity") for the purpose of (i) reporting a possible violation of any U.S. federal, state, or local law or regulation, (ii) participating in any investigation or proceeding that may be conducted or managed by any Government Entity, including by providing documents or other

------

information, or (iii) filing a charge or complaint with a Government Entity, provided that in each case, such communications, participation, and disclosures are consistent with applicable law. Additionally, Employee shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that is made (i) in confidence to a federal, state, or local government official, or to an attorney, solely for the purpose of reporting or investigating a suspected violation of law, or (ii) in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal. If Employee files a lawsuit for retaliation by an employer for reporting a suspected violation of law, Employee may disclose the trade secret to Employee's attorney and use the trade secret information in the court proceeding, if Employee files any document containing the trade secret under seal; and does not disclose the trade secret, except pursuant to court order.

Notwithstanding anything herein to the contrary, in light of Employee's continuing service on the Company's Board of Directors as described in Section 7 hereof and to facilitate the transition of Employee's responsibilities to Employee's successor, Employee shall be entitled to retain the Company-owned laptop currently being used by Employee and have access to Company systems and data for so long as Employee remains a member of the Board of Directors and for so long as mutually agreed by Employee and the Company.

14.<u>Post-Employment Restrictive Covenants</u>

Employee acknowledges that the provisions of the Employment Agreement that are designed to survive the termination of the Employment Agreement shall survive in full force and effect for the applicable periods contained therein. For the avoidance of doubt, such provisions of the Employment Agreement that shall survive the termination of the Employment Agreement include, without limitation, Section 12 (Confidential Information), Section 13 (Non-Competition), Section 14 (Non-Solicitation), Section 15(c) and (d) (Intellectual Property), Section 16 (Nondisparagement) and Section 17 (Acknowledgements) (collectively, the "Post-Employment Restrictive Covenants").

15.<u>Return of Physical Property by Employee</u>

Subject to the last paragraph of Section 13 above, Employee acknowledges Employee's immediate responsibility to fully and unconditionally return all tangible property of Hain to Hain on or before the Termination Date. Employee acknowledges that prior to Employee's termination, Employee will not alter or remove any Hain related data or documents from any electronic property of the Company and Employee will return all electronic property in full working order.

16.<u>Nondisparagement</u>

Employee agrees to refrain from any defamation, libel or slander of Hain or any of the Releasees to any person or entity including but not limited to Hain's past, present or future customers, employees, clients, contractors, vendors, or to the media or consumer packaged goods community via any form of communication including written, oral, or electronic. Employee also agrees not to publish, discuss or comment on any remarks related to Hain or any of the other Releasees in any forum, including the internet, any web site or blog. Further, Employee agrees to refrain from any tortious interference with Hain's or the Releasees' contracts and relationships. If Hain's Human Resources representatives are contacted by any potential future employers of Employee for a reference, Hain's Human Resources representative shall provide Employee's dates of employment and last position at Hain.

------

17.<u>No Consideration Absent Execution of this Agreement</u>

Employee agrees and understands that the Company has no obligation to pay or provide (A) the severance payments provided by Section 2 hereof, (B) the prorated annual bonus opportunity under the 2023 AIP provided by Section 3 hereof, (C) the prorated continuation of the FY23 LTIP PSUs provided by the second paragraph of Section 4 hereof or (D) the benefits provided by Section 5 hereof unless Employee signs this Agreement and follows its terms.

18.<u>Entire Agreement and Severability</u>

The parties hereto agree that this Agreement may not be modified, altered or changed, except by a written agreement signed by the parties hereto. This Agreement represents the entire agreement and understanding between Hain and Employee concerning the subject matter of this Agreement and Employee's relationship with Hain, and supersedes and replaces any and all prior agreements and understandings between the parties concerning the subject matter of this Agreement and Employee's relationship with Hain, provided that as set forth in Section 14 above, the provisions of the Employment Agreement that are designed to survive the termination of the Employment Agreement, including without limitation the Post-Employment Restrictive Covenants, shall survive in full force and effect for the applicable periods contained therein. If any provision of this Agreement is held to be invalid, the court rendering that finding shall interpret or modify each such clause to be enforceable to fulfill the parties' stated intent. If that cannot be done, such clause(s) shall be void and the remaining provisions shall remain in full force and effect. If any term or provision of this Agreement or the application thereof to Employee or circumstance shall to any extent be invalid or unenforceable, such provision will be modified, rewritten or interpreted by the parties to include as much of its nature and scope as will render it enforceable. Otherwise, Hain shall be entitled to the return of the entire consideration under this Agreement.

19.<u>Breach of Agreement or Post-Employment Restrictive Covenants</u>

Employee acknowledges and agrees that should Employee breach this Agreement or the Post-Employment Restrictive Covenants, the Company shall be entitled immediately to recover 95% of the severance payments, other payments and benefits set forth in Sections 2 through 5 already provided and to cease any outstanding consideration without impacting Employee's release of claims and other obligations hereunder, without limitation to any other remedies, including equitable remedies. In addition, Hain shall be entitled to recover its costs and fees, including reasonable attorneys' fees, incurred in the successful enforcement of any such relief.

20.<u>Resolution of Disputes/Waiver of Jury Trial</u>

Any controversy or claim arising out of this Agreement, or the breach thereof, shall be decided by an appropriate state or federal court nearest to Hain's corporate headquarters, **and all such claims shall be adjudicated by a judge sitting without a jury.**

21.<u>Governing Law</u>

This Agreement shall be governed by the laws of the State of New York, without regard for choice of law provisions.

------

22.<u>Effective Date</u>

This Agreement is effective after it has been signed by both parties and after eight (8) days have passed following the date of Employee's signature on the Agreement (the "Effective Date"). Any revocation prior to the eighth day after the date of Employee's signature must be submitted, in writing, to JoAnn Murray, Executive Vice President, Chief Human Resources Officer and state, "I hereby revoke my acceptance of our Separation Agreement and General Release." The revocation must be delivered to JoAnn Murray and postmarked within seven (7) calendar days of execution of this Agreement.

23.<u>Capability to Waive Claims</u>

Employee is competent to effect a knowing and voluntary general and unlimited release of all claims and to enter into this Agreement. Employee is not affected or impaired in Employee's ability voluntarily and knowingly to consider and to execute this Agreement, whether by illness, use of alcohol, drugs or other substances or conditions. Employee is not a party to any bankruptcy, lien, assignment, creditor-debtor or other proceeding which would impair the right to settle all claims against Hain or to waive all claims that Employee may have against Released Parties.

24.<u>Voluntary Execution</u>

Employee acknowledges that Employee has carefully read this Agreement and understands all of its terms including the general and final release of claims set forth above and covenant not to sue. Employee further acknowledges that Employee has voluntarily entered into this Agreement; that Employee has not relied upon any representation or statement, written or oral, not set forth in this Agreement; that the only consideration for signing this Agreement is as set forth herein; that the consideration received for executing this Agreement is greater than that to which Employee may otherwise be entitled; and that this document gives Employee the opportunity and encourages Employee to have this Agreement reviewed by Employee's attorney and tax advisor.

**EMPLOYEE HAS UP TO TWENTY-ONE (21) CALENDAR DAYS TO CONSIDER THIS AGREEMENT. EMPLOYEE ALSO IS ADVISED TO CONSULT WITH AN ATTORNEY PRIOR TO SIGNING THIS AGREEMENT.** 

**EMPLOYEE AGREES THAT ANY MODIFICATIONS, MATERIAL OR OTHERWISE, MADE TO THIS AGREEMENT, DO NOT RESTART OR AFFECT IN ANY MANNER THE ORIGINAL TWENTY-ONE (21) CALENDAR DAY CONSIDERATION PERIOD.**

**EMPLOYEE MAY REVOKE THIS AGREEMENT DURING THE SEVEN (7) CALENDAR DAYS FOLLOWING THE DAY EMPLOYEE SIGNS THIS AGREEMENT. ANY REVOCATION WITHIN THIS PERIOD MUST BE SUBMITTED, IN WRITING, TO JOANN MURRAY, EXECUTIVE VICE PRESIDENT, CHIEF HUMAN RESOURCES OFFICER AND STATE, "I HEREBY REVOKE MY ACCEPTANCE OF OUR SEPARATION AGREEMENT AND GENERAL RELEASE." THE REVOCATION MUST BE PERSONALLY DELIVERED TO JOANN MURRAY OR HER DESIGNEE, OR MAILED TO JOANN MURRAY AT THE HAIN CELESTIAL GROUP, INC., 1111 MARCUS AVENUE, LAKE SUCCESS, NEW YORK 11042 AND POSTMARKED WITHIN SEVEN (7) CALENDAR DAYS AFTER EMPLOYEE SIGNS THIS AGREEMENT.**

**EMPLOYEE FREELY AND KNOWINGLY, AND AFTER DUE CONSIDERATION, ENTERS INTO THIS AGREEMENT INTENDING TO** 

------

**WAIVE, SETTLE AND RELEASE ALL CLAIMS AGAINST HAIN AND RELEASEES.**

*[Signature Page Follows]*

------

The parties knowingly and voluntarily sign this Agreement as of the date(s) set forth below:

---

| | | |
|:---|:---|:---|
| | | THE HAIN CELESTIAL GROUP, INC. |
| <u>/s/ Mark L. Schiller</u> | By: | <u>/s/ Dawn M. Zier</u> |
| Mark L. Schiller |  | Dawn M. Zier |
|  |  | Chair of the Board |
| Date: December 31, 2022 |  | Date: December 31, 2022 |

---

## Exhibit 31.1

**EXHIBIT 31.1** 

<u>CERTIFICATION</u>

I, Wendy P. Davidson, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.I have reviewed this quarterly report on Form 10-Q of The Hain Celestial Group, Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth quarter fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Dated: February 7, 2023

---

| |
|:---|
| /s/Wendy P. Davidson |
| Wendy P. Davidson<br>President and Chief Executive Officer |

---

## Exhibit 31.2

**EXHIBIT 31.2**

<u>CERTIFICATION</u>

I, Christopher J. Bellairs, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.I have reviewed this quarterly report on Form 10-Q of The Hain Celestial Group, Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth quarter fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Dated: February 7, 2023

---

| |
|:---|
| /s/ Christopher J. Bellairs |
| Christopher J. Bellairs<br>Executive Vice President and Chief Financial Officer |

---

## Exhibit 32.1

**EXHIBIT 32.1** 

**CERTIFICATION FURNISHED** 

**PURSUANT TO 18 U.S.C. SECTION 1350,** 

**AS ADOPTED PURSUANT TO SECTION 906** 

**OF THE SARBANES-OXLEY ACT OF 2002** 

I, Wendy P. Davidson, President and Chief Executive Officer of The Hain Celestial Group, Inc. (the "Company"), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that to my knowledge:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The Quarterly Report on Form 10-Q of the Company for the quarter ended December 31, 2022 (the "Report") fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 (15 U.S.C. 78m); and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: February 7, 2023

---

| |
|:---|
| /s/ Wendy P. Davidson |
| Wendy P. Davidson<br>President and Chief Executive Officer |

---

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff on request.

## Exhibit 32.2

**EXHIBIT 32.2** 

**CERTIFICATION FURNISHED** 

**PURSUANT TO 18 U.S.C. SECTION 1350,** 

**AS ADOPTED PURSUANT TO SECTION 906** 

**OF THE SARBANES-OXLEY ACT OF 2002** 

I, Christopher J. Bellairs, Executive Vice President and Chief Financial Officer of The Hain Celestial Group, Inc. (the "Company"), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that to my knowledge:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The Quarterly Report on Form 10-Q of the Company for the quarter ended December 31, 2022 (the "Report") fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 (15 U.S.C. 78m); and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: February 7, 2023

---

| |
|:---|
| /s/ Christopher J. Bellairs |
| Christopher J. Bellairs<br>Executive Vice President and Chief Financial Officer |

---

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff on request.

<br>